Home Other Building Blocks 50-35-1
50-35-1,MFCD00153873
Catalog No.:AA006UKW
50-35-1 | Thalidomide
Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98+%
in stock  
$14.00
- +
5g
98+%
in stock  
$42.00
- +
10g
98+%
in stock  
$66.00
- +
25g
98+%
in stock  
$133.00
- +
100g
98+%
in stock  
$380.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Q & A
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA006UKW
Chemical Name:
Thalidomide
CAS Number:
50-35-1
Molecular Formula:
C13H10N2O4
Molecular Weight:
258.2295
MDL Number:
MFCD00153873
IUPAC Name:
2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
InChI:
InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
InChI Key:
UEJJHQNACJXSKW-UHFFFAOYSA-N
SMILES:
O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2
EC Number:
200-031-1
UN Number:
2811
Properties
Computed Properties
 
Complexity:
449  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
258.064g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
258.233g/mol
Monoisotopic Mass:
258.064g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
83.6A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.3  

Synonyms
 
Sedoval 
Thalidomide 
Psycholiquid 
Glutarimide, 2-phthalimido- 
NSC-66847 
alpha-(N-Phthalimido)glutarimide 
Talidomida [INN-Spanish] 
Thalidomidum [INN-Latin] 
Thalidomine USP26 
K 17 
E-217 
ENMD 0995 
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)- 
Psychotablets 
1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline 
.alpha.-N-Phthalylglutaramide 
N-Phthalyl-glutaminsaeure-imid [German] 
N-Phthalimidoglutamic acid imide 
2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione 
HSDB 3586 
Phthalimide, N-(2,6-dioxo-3-piperidyl)- 
C13H10N2O4 
EINECS 200-031-1 
CHEMBL468 
Theophilcholine 
Thalidomide (soluble form) 
NSC 527179 
BRN 0030233 
.alpha.-Phthalimidoglutarimide 
AI3-50606 
2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione 
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione 
(+-)-N-(2,6-Dioxo-3-piperidyl)phthalimide 
CHEBI:74947 
UEJJHQNACJXSKW-UHFFFAOYSA-N 
Algosediv 
.alpha.-(N-Phthalimido)glutarimide 
NSC66847 
2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione 
MFCD00153873 
N-(2,6-dioxo-3-piperidinyl)phthalimide 
NCGC00015989-09 
Talidomide 
(+/-)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione 
DSSTox_CID_2524 
DSSTox_RID_76611 
Asmadion 
(+/-)-N-(2,6-Dioxo-3-piperidinyl)phthalimide 
DSSTox_GSID_22524 
2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione 
2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione 
Synovir 
Talizer 
(?)-Thalidomide 
Thaled 
Phthalimide,6-dioxo-3-piperidyl)- 
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (+-)- 
Bonbrain 
WLN: T56 BVNVJ C- DT6VMVTJ 
Thalomid (TM) 
Thalomid (TN) 
Thalidomide Pharmion 
Thaled (TN) 
Thalidomide [USAN:INN:BAN] 
1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)- 
SR-01000076184 
Thalidomide (+ and -) 
Celgene 
Calmorex 
Pharmion 
Talinol 
Thalidomide (JAN/USP/INN) 
CCRIS 8148 
(y)-Thalidomide 
Thalidomide,(S) 
CAS-50-35-1 
Prestwick_463 
THALIDOMIDE (AIDS INITIATIVE) 
IN1061 
Contergan 
Thalidomide [USAN:USP:INN:BAN:JAN] 
(A+/-)-Thalidomide 
AC1L1KBZ 
AC1Q6FJA 
Prestwick0_000192 
Prestwick1_000192 
Prestwick2_000192 
Prestwick3_000192 
Spectrum2_000707 
Spectrum3_001715 
Distaval 
Spectrum4_001087 
Spectrum5_001791 
(.+/-.)-Thalidomide 
UPCMLD-DP139 
Thalomid (TN) (Celgene) 
SCHEMBL7581 
NCIOpen2_003188 
Lopac0_001224 
BSPBio_000143 
BSPBio_001156 
Ectiluran 
BSPBio_003330 
KBioGR_000496 
KBioGR_001474 
KBioGR_002322 
KBioSS_000496 
KBioSS_002324 
MLS000069353 
ARONIS24496 
DivK1c_000051 
SPECTRUM1503607 
Thalomid 
Enterosediv 
SPBio_000893 
SPBio_002064 
BPBio1_000159 
GTPL7327 
DTXSID9022524 
SCHEMBL15197560 
UPCMLD-DP139:001 
CTK8B6291 
HMS500C13 
KBio1_000051 
Gastrinide 
KBio2_000496 
KBio2_002322 
KBio2_003064 
KBio2_004890 
KBio2_005632 
KBio2_007458 
KBio3_000911 
KBio3_000912 
KBio3_002550 
KBio3_002802 
Glutanon 
cMAP_000022 
NINDS_000051 
Bio1_000387 
Bio1_000876 
Bio1_001365 
Bio2_000418 
Bio2_000898 
HMS1362J17 
HMS1568H05 
HMS1792J17 
Hippuzon 
HMS1922E12 
HMS1990J17 
HMS2090O05 
HMS2093G15 
HMS2095H05 
HMS2234C07 
HMS3259C22 
HMS3263F10 
HMS3266F13 
HMS3373E06 
Neosedyn 
HMS3373G15 
HMS3403J17 
HMS3654A20 
HMS3678F19 
HMS3712H05 
Pharmakon1600-01503607 
BCP19772 
NSC91729 
NSC91730 
Tox21_110275 
Neosydyn 
Tox21_300580 
Tox21_501224 
AC-917 
ANW-53225 
BBL023439 
BDBM50070114 
CCG-39878 
LS-140 
NSC-91729 
NSC-91730 
Nerosedyn 
NSC527179 
NSC758479 
STL356025 
( inverted question mark)-Thalidomide 
AKOS009529198 
Tox21_110275_1 
CS-1084 
DB01041 
LP01224 
MCULE-6327754946 
Neufatin 
NC00600 
NSC-527179 
NSC-758479 
RP29207 
(+/-)-Thalidomide, >=98%, powder 
IDI1_000051 
IDI1_002173 
KS-00000H64 
n-(2,6-dioxopiperidin-3-yl)phthalimide 
NCGC00015989-03 
Neurodyn 
NCGC00015989-04 
NCGC00015989-05 
NCGC00015989-06 
NCGC00015989-07 
NCGC00015989-08 
NCGC00015989-10 
NCGC00015989-11 
NCGC00015989-12 
NCGC00015989-13 
NCGC00015989-14 
Neurosedin 
NCGC00015989-16 
NCGC00015989-17 
NCGC00024708-02 
NCGC00024708-03 
NCGC00024708-04 
NCGC00024708-05 
NCGC00024708-06 
NCGC00024708-07 
NCGC00024708-08 
NCGC00024708-09 
thalidomide 
Neurosedym 
NCGC00024708-10 
NCGC00024708-11 
NCGC00254343-01 
NCGC00261909-01 
AK-91024 
AN-15419 
AS-12367 
BC204656 
CPD000058524 
HY-14658 
Nevrodyn 
NCI60_023904 
SAM002564245 
SC-18573 
SMR000058524 
WLN: T56 BVNVJ C- DT6VMVTJ -D 
WLN: T56 BVNVJ C- DT6VMVTJ -L 
SBI-0051191.P003 
AB0011813 
AB2000009 
LS-109463 
Noctosediv 
Phthalimide,6-dioxo-3-piperidyl)-, (+)- 
Phthalimide,6-dioxo-3-piperidyl)-, (-)- 
TC-141970 
AB00052362 
EU-0101224 
FT-0600001 
FT-0631211 
S1193 
ST24027458 
ST51039042 
Pantosediv 
SW196678-4 
Phthalimide,6-dioxo-3-piperidyl)-, D-(+)- 
Phthalimide,6-dioxo-3-piperidyl)-, L-(-)- 
(+/-)-N-(2,6-dioxo-3-piperidyl)phthalimide 
C07910 
D00754 
J90042 
M-1523 
AB00052362-11 
AB00052362-12 
Polygripan 
AB00052362-13 
AB00052362_14 
AB00052362_15 
153T873 
I06-0197 
SR-01000076184-1 
SR-01000076184-3 
SR-01000076184-5 
SR-01000076184-8 
W-105969 
Profarmil 
BRD-A93255169-001-04-4 
BRD-A93255169-001-06-9 
BRD-A93255169-001-24-2 
I14-23643 
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+-)- 
Z1550675451 
1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (R)- 
1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (S)- 
2-(2,6-dioxoazaperhydroin-3-yl)benzo[c]azoline-1,3-dione 
2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione # 
Quetimid 
[(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione 
Thalidomide, United States Pharmacopeia (USP) Reference Standard 
( inverted question mark)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione 
2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione 
1012310-87-0 
Ulcerfen 
Actimid 
Lulamin 
l-Thalidomide 
thalidomid- 
Quietoplex 
D-Thalidomide 
(+)-Thalidomide 
(-)-Thalidomide 
(S)-Thalidomide 
Thalidomide, L- 
( -)-Thalidomide 
IMIDAN 
Thalomid, Thalidomide 
S-(-)-Thalidomide 
Thalidomide (+ and-) 
Sandormin 
UNII-4Z8R6ORS6L 
N-phthal-nu-oylglutamimide 
D0U7GK 
4Z8R6ORS6L 
Celgene Brand of Thalidomide 
UNII-TG87FSR590 
Thalidomide [USAN:BAN:INN] 
2-(2,5-dimethylphenyl)pyridine 
CID5426 
CC 4047 
Sedimide 
DRG-0184 
(inverted question mark)-Thalidomide 
NA2811 
NSC 91730 
UN2811 
C13-H10-N2-O4 
CS-O-02490 
Thalidomide, 98% - 500mg 500mg 
T-144 
T2524 
50-35-1 
Sedisperil 
5-22-13-00224 (Beilstein Handbook Reference) 
D013792 
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (-)- 
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (.+.)- 
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, L-(-)- 
Neo 
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (.+.)- 
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (S)- 
841-67-8 
2614-06-4 
Shinnibrol 
731-40-8 
Softenil 
Softenon 
Talargan 
Talismol 
Telargean 
Tensival 
Thalinette 
Valgraine 
Thalomid 
Asmaval 
Calmore 
Glupan 
Grippex 
Imidene 
Isomin 
Kevadon 
Nibrol 
Noxodyn 
Pangul 
Sedoval 
Sleepan 
Slipro 
Talimol 
Telagan 
Thalin 
Valgis 
Yodomin 
N-Phthaloylglutamimide 
Sedin 
Predni-Sediv 
(+/-)-THALIDOMIDE 
Imida-lab 
Poly-Giron 
Sedalis sedi-lab 
Shin-naito S 
Neaufatin 
Asidon 3 
Pro-ban M 
Imidan (peyta) 
N-Phthalylglutamic acid imide 
Talidomida 
2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 
3-Phthalimidoglutarimide 
alpha-Phthalimidoglutarimide 
Thalidomidum 
Bonbrrin 
Distaxal 
Distoval 
Thalomide 
Kedavon 
(+-)-Thalidomide 
K-17 
Corronarobetin 
2,6-Dioxo-3-phthalimidopiperidine 
N-Phthalyl-glutaminsaeure-imid 
Thalidomide Celgene 
Pro-Bam M 
Talidomide [DCIT] 
alpha-N-Phthalylglutaramide 
Neurosedyn 
Sedalis 
Telargan 
N-(2,6-Dioxo-3-piperidyl)phthalimide 
Literature

Title: Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome.

Journal: eLife 20180101

Title: Transcriptomic Analysis of Thalidomide Challenged Chick Embryo Suggests Possible Link between Impaired Vasculogenesis and Defective Organogenesis.

Journal: Chemical research in toxicology 20171016

Title: The Dihydroxy Metabolite of the Teratogen Thalidomide Causes Oxidative DNA Damage.

Journal: Chemical research in toxicology 20170821

Title: Induction of human cytochrome P450 3A enzymes in cultured placental cells by thalidomide and relevance to bioactivation and toxicity.

Journal: The Journal of toxicological sciences 20170101

Title: Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans.

Journal: Reproductive toxicology (Elmsford, N.Y.) 20161201

Title: Select putative neurodevelopmental toxins modify SNAP-25 expression in primary cultures of rat cerebellar granule cells.

Journal: Toxicology 20160831

Title: Assessment of Protein Binding of 5-Hydroxythalidomide Bioactivated in Humanized Mice with Human P450 3A-Chromosome or Hepatocytes by Two-Dimensional Electrophoresis/Accelerator Mass Spectrometry.

Journal: Chemical research in toxicology 20160815

Title: A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.

Journal: Nature 20160714

Title: Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.

Journal: Nature medicine 20160701

Title: Mantle Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20160410

Title: Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.

Journal: Blood cancer journal 20151001

Title: Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.

Journal: Chemico-biological interactions 20150905

Title: Transcriptomic changes in mouse embryonic stem cells exposed to thalidomide during spontaneous differentiation.

Journal: Data in brief 20150901

Title: Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells.

Journal: Toxicology and applied pharmacology 20150815

Title: Anti-inflammatory effect of thalidomide dithiocarbamate and dithioate analogs.

Journal: Chemico-biological interactions 20150805

Title: Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.

Journal: Chemistry & biology 20150618

Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

Journal: Chemical research in toxicology 20150518

Title: Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis.

Journal: Expert opinion on pharmacotherapy 20150501

Title: The effect of thalidomide on ethanol-induced gastric mucosal damage in mice: involvement of inflammatory cytokines and nitric oxide.

Journal: Chemico-biological interactions 20150105

Title: Protective effects of thalidomide on pulmonary injuries in a rat model of paraquat intoxication.

Journal: Journal of inflammation (London, England) 20150101

Title: [Effect of thalidomide in a mouse model of paraquat-induced acute lung injury and the underlying mechanisms].

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 20141101

Title: Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.

Journal: Leukemia 20141001

Title: Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity.

Journal: Cellular signalling 20140901

Title: Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs.

Journal: Nature structural & molecular biology 20140901

Title: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.

Journal: Nature 20140807

Title: Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients.

Journal: International journal of hematology 20140801

Title: A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology.

Journal: Dermatology online journal 20140516

Title: Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptor.

Journal: Chemical research in toxicology 20140217

Title: Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomide.

Journal: Chemical research in toxicology 20140121

Title: The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.

Journal: Oncogene 20140116

Title: 'Real-world' data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group.

Journal: Annals of hematology 20140101

Title: A high-throughput screen for teratogens using human pluripotent stem cells.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20140101

Title: Myelofibrosis: an update on current pharmacotherapy and future directions.

Journal: Expert opinion on pharmacotherapy 20130501

Title: Pomalidomide and myeloma meningitis.

Journal: Leukemia & lymphoma 20130401

Title: Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma.

Journal: Leukemia & lymphoma 20130401

Title: [Effect of thalidomide in a mouse model of paraquat-induced acute lung injury and the underlying mechanisms].

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 20130301

Title: Pharmacotherapy for sarcoidosis: an example of an off-label procedure.

Journal: Advances in experimental medicine and biology 20130101

Title: Phosphodiesterase 4-targeted treatments for autoimmune diseases.

Journal: BMC medicine 20130101

Title: Activation of coagulation by lenalidomide-based regimens for the treatment of multiple myeloma.

Journal: PloS one 20130101

Title: Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment.

Journal: Cancer treatment reviews 20121201

Title: Pharmacokinetics and tissue disposition of lenalidomide in mice.

Journal: The AAPS journal 20121201

Title: Enantiomerization mechanism of thalidomide and the role of water and hydroxide ions.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20121105

Title: Palliative chemotherapy for malignant ascites secondary to ovarian cancer.

Journal: The American journal of hospice & palliative care 20121101

Title: Fifty years after thalidomide; what role for drug regulators?

Journal: British journal of clinical pharmacology 20121101

Title: Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice.

Journal: Obesity (Silver Spring, Md.) 20121101

Title: Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.

Journal: Leukemia 20121101

Title: Neurological manifestations of TB-IRIS: a report of 4 children.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20121101

Title: Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan.

Journal: Annals of hematology 20121101

Title: Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101

Title: (Bortezomib plus lenalidomide/thalidomide)- vs. (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.

Journal: Annals of hematology 20121101

Title: A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study.

Journal: Gynecologic oncology 20121101

Title: Model of translational cancer research in multiple myeloma.

Journal: Cancer science 20121101

Title: Phase I trial of pomalidomide given for patients with advanced solid tumors.

Journal: Cancer chemotherapy and pharmacology 20121101

Title: Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines.

Journal: Cytokine 20121101

Title: Pomalidomide is effective for prevention and treatment of experimental skin fibrosis.

Journal: Annals of the rheumatic diseases 20121101

Title: CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma.

Journal: Leukemia research 20121101

Title: Single-dose pharmacokinetics of lenalidomide in healthy volunteers: dose proportionality, food effect, and racial sensitivity.

Journal: Cancer chemotherapy and pharmacology 20121101

Title: Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome.

Journal: Blood 20121025

Title: Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS.

Journal: AIDS (London, England) 20121023

Title: Carfilzomib: in relapsed, or relapsed and refractory, multiple myeloma.

Journal: Drugs 20121022

Title: [Thalidomide associated to endoscopic treatment with argon plasma coagulation in rectal bleeding caused by vascular injury secundary to severe actinic proctitis].

Journal: Medicina clinica 20121006

Title: A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.

Journal: Blood 20121004

Title: Lenalidomide: a new treatment option for Castleman disease.

Journal: Leukemia & lymphoma 20121001

Title: Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20121001

Title: Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice.

Journal: Immunopharmacology and immunotoxicology 20121001

Title: Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.

Journal: Journal of molecular medicine (Berlin, Germany) 20121001

Title: Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20121001

Title: A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities.

Journal: Clinical lymphoma, myeloma & leukemia 20121001

Title: Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q).

Journal: Clinical lymphoma, myeloma & leukemia 20121001

Title: Combination of low doses of enzastaurin and lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines.

Journal: Annals of hematology 20121001

Title: Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20121001

Title: Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.

Journal: Experimental hematology 20121001

Title: Novel agents in Hodgkin lymphoma.

Journal: Current oncology reports 20121001

Title: Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.

Journal: Gastroenterologia y hepatologia 20121001

Title: The application and biology of immunomodulatory drugs (IMiDs) in cancer.

Journal: Pharmacology & therapeutics 20121001

Title: Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20121001

Title: The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study.

Journal: Journal of palliative medicine 20121001

Title: Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.

Journal: British journal of haematology 20121001

Title: Lenalidomide maintenance in myeloma.

Journal: Nature reviews. Clinical oncology 20121001

Title: Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma: a feasibility study in Japanese population.

Journal: International journal of hematology 20121001

Title: Effect of low-dose thalidomide on dopaminergic neuronal differentiation of human neural progenitor cells: a combined study of metabolomics and morphological analysis.

Journal: Neurotoxicology 20121001

Title: Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma.

Journal: Clinical lymphoma, myeloma & leukemia 20121001

Title: An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.

Journal: Clinical lymphoma, myeloma & leukemia 20121001

Title: Lenalidomide for del(5q) and non-del(5q) myelodysplastic syndromes.

Journal: Seminars in hematology 20121001

Title: Revisiting thalidomide: fighting with caution against idiopathic pulmonary fibrosis.

Journal: Drugs of today (Barcelona, Spain : 1998) 20121001

Title: Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.

Journal: Blood 20120927

Title: Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.

Journal: Annals of internal medicine 20120918

Title: Summaries for patients. Thalidomide treatment for cough in patients with idiopathic pulmonary fibrosis.

Journal: Annals of internal medicine 20120918

Title: A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

Journal: Cancer cell 20120911

Title: Thalidomide manufacturer offers apology but no compensation.

Journal: BMJ (Clinical research ed.) 20120904

Title: Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents.

Journal: Hematological oncology 20120901

Title: Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: case report and literature review.

Journal: Journal of clinical pharmacology 20120901

Title: Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma.

Journal: International journal of cancer 20120901

Title: Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.

Journal: Pediatric blood & cancer 20120901

Title: Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.

Journal: Acta oncologica (Stockholm, Sweden) 20120901

Title: Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma.

Journal: Leukemia & lymphoma 20120901

Title: Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience.

Journal: Leukemia & lymphoma 20120901

Title: Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trial.

Journal: Leukemia & lymphoma 20120901

Title: Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.

Journal: Leukemia & lymphoma 20120901

Title: The role of natural killer cells in immunity against multiple myeloma.

Journal: Leukemia & lymphoma 20120901

Title: Deferasirox treatment for myelodysplastic syndromes: 'real-life' efficacy and safety in a single-institution patient population.

Journal: Annals of hematology 20120901

Title: Management of inflammatory bowel disease in pregnancy.

Journal: Journal of Crohn's & colitis 20120901

Title: The role of IMiDs alone or in combination in prostate cancer.

Journal: Clinical genitourinary cancer 20120901

Title: Relapse of liver amyloidosis 6 years after autologous stem cell transplantation.

Journal: American journal of hematology 20120901

Title: Novel targets and derived small molecule inhibitors in multiple myeloma.

Journal: Current cancer drug targets 20120901

Title: Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium.

Journal: Current cancer drug targets 20120901

Title: Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations.

Journal: European journal of haematology 20120901

Title: 3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.

Journal: Journal of neurochemistry 20120901

Title: Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide.

Journal: International journal of oncology 20120901

Title: Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity.

Journal: British journal of haematology 20120901

Title: Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma.

Journal: Expert opinion on drug metabolism & toxicology 20120901

Title: Multiple myeloma: improved outcomes with new therapeutic approaches.

Journal: Current opinion in supportive and palliative care 20120901

Title: Biological therapy doublets: pairing rituximab with interferon, lenalidomide, and other biological agents in patients with follicular lymphoma.

Journal: Current hematologic malignancy reports 20120901

Title: Emerging biological insights and novel treatment strategies in multiple myeloma.

Journal: Expert opinion on emerging drugs 20120901

Title: Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspective.

Journal: Advances in chronic kidney disease 20120901

Title: Thalidomide and its sequelae.

Journal: Lancet (London, England) 20120901

Title: Effects of exercise on fatigue, sleep, and performance: a randomized trial.

Journal: Oncology nursing forum 20120901

Title: Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial.

Journal: Haematologica 20120901

Title: How to select among available options for the treatment of multiple myeloma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120901

Title: Lenalidomide-associated hepatotoxicity--a case report and literature review.

Journal: Anticancer research 20120901

Title: [Our experience in treatment of multicentric plasma-cell Castleman disease associated with vasculitis manifestations - case report and literature review].

Journal: Vnitrni lekarstvi 20120901

Title: Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

Journal: Neuro-oncology 20120901

Title: A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.

Journal: Blood 20120830

Title: Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial.

Journal: Lancet (London, England) 20120825

Title: Apremilast: a step forward in the treatment of psoriasis?

Journal: Lancet (London, England) 20120825

Title: Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance.

Journal: Blood 20120823

Title: Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.

Journal: Blood 20120823

Title: Second to none.

Journal: Blood 20120823

Title: Improving the outlook for myelodysplastic syndrome.

Journal: Journal of the National Cancer Institute 20120822

Title: Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120820

Title: Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.

Journal: Blood 20120816

Title: A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).

Journal: Cancer 20120815

Title: Lenalidomide for multiple myeloma.

Journal: The New England journal of medicine 20120809

Title: Corneal snowflakes.

Journal: Lancet (London, England) 20120804

Title: In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors.

Journal: Investigational new drugs 20120801

Title: Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab.

Journal: Cancer 20120801

Title: Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy.

Journal: The Journal of dermatology 20120801

Title: Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.

Journal: Journal of clinical pathology 20120801

Title: Management of adult primary vulvar Langerhans cell histiocytosis: review of the literature and a case history.

Journal: European journal of obstetrics, gynecology, and reproductive biology 20120801

Title: Bortezomib combined with thalidomide and dexamethasone is effective for patient with crystal-storing histiocytosis associated with monoclonal gammopathy of undermined significance.

Journal: European journal of haematology 20120801

Title: Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis.

Journal: Leukemia research 20120801

Title: Rituximab and thalidomide combination therapy for Castleman disease.

Journal: British journal of haematology 20120801

Title: Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study.

Journal: British journal of haematology 20120801

Title: Immunomodulatory agents in myelofibrosis.

Journal: Expert opinion on investigational drugs 20120801

Title: Evaluation of flocculants for the recovery of freshwater microalgae.

Journal: Bioresource technology 20120801

Title: Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma.

Journal: British journal of haematology 20120801

Title: Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma.

Journal: International journal of hematology 20120801

Title: Development, validation and application of a sensitive LC-MS/MS method for the quantification of thalidomide in human serum, cells and cell culture medium.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120801

Title: Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.

Journal: Clinical and experimental immunology 20120801

Title: POEMS syndrome: update on diagnosis, risk-stratification, and management.

Journal: American journal of hematology 20120801

Title: Thalidomide therapy for aggressive histiocytic lesions in the pediatric population.

Journal: Journal of pediatric hematology/oncology 20120801

Title: Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trial.

Journal: Anticancer research 20120801

Title: Effects of brucine on vascular endothelial growth factor expression and microvessel density in a nude mouse model of bone metastasis due to breast cancer.

Journal: Chinese journal of integrative medicine 20120801

Title: [Action mechanism of lenalidomide in hematological malignancies - review].

Journal: Zhongguo shi yan xue ye xue za zhi 20120801

Title: Role of carfilzomib in the treatment of multiple myeloma.

Journal: Expert review of hematology 20120801

Title: Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.

Journal: Cancer 20120715

Title: Risk assessment models for cancer-associated venous thromboembolism.

Journal: Cancer 20120715

Title: Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710

Title: Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710

Title: Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Journal: Blood 20120705

Title: Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma.

Journal: Leukemia & lymphoma 20120701

Title: Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma.

Journal: Leukemia & lymphoma 20120701

Title: Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701

Title: A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma.

Journal: Annals of hematology 20120701

Title: Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma.

Journal: Leukemia 20120701

Title: A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.

Journal: Leukemia 20120701

Title: Pulmonary zygomycosis in a non-neutropenic patient with myelodysplastic syndrome on lenalidomide.

Journal: Respiratory care 20120701

Title: Multiple myeloma and immunomodulation: regulating the regulatory cells.

Journal: Leukemia & lymphoma 20120701

Title: Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma.

Journal: Experimental hematology 20120701

Title: Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.

Journal: Archives of dermatology 20120701

Title: Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701

Title: Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.

Journal: International journal of hematology 20120701

Title: Effect of an angiogenesis inhibitor on hepatic tumor perfusion and the implications for adjuvant cytotoxic therapy.

Journal: Radiology 20120701

Title: Synthesis and antimycobacterial activity of some phthalimide derivatives.

Journal: Bioorganic & medicinal chemistry 20120701

Title: Carbamazepine use in pregnancy and coincidental thalidomide-like phocomelia in a newborn.

Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20120701

Title: Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.

Journal: The Lancet. Oncology 20120701

Title: Bortezomib combination therapy in multiple myeloma.

Journal: Seminars in hematology 20120701

Title: Management strategies for relapsed/refractory multiple myeloma: current clinical perspectives.

Journal: Seminars in hematology 20120701

Title: Relapsed/Refractory multiple myeloma: defining refractory disease and identifying strategies to overcome resistance.

Journal: Seminars in hematology 20120701

Title: The future of therapy for relapsed/refractory multiple myeloma: emerging agents and novel treatment strategies.

Journal: Seminars in hematology 20120701

Title: Blood vessel normalization in the hamster oral cancer model for experimental cancer therapy studies.

Journal: Anticancer research 20120701

Title: Drug transfer to the fetus and to the breastfeeding infant: what do we know?

Journal: Current drug delivery 20120701

Title: Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120701

Title: Treatment of refractory prurigo nodularis with lenalidomide.

Journal: Archives of dermatology 20120701

Title: Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

Journal: Blood 20120628

Title: Analgesic effect of magnetic stimulation on paclitaxel-induced peripheral neuropathic pain in mice.

Journal: Brain research 20120621

Title: Apremilast mechanism of action and application to psoriasis and psoriatic arthritis.

Journal: Biochemical pharmacology 20120615

Title: Bortezomib induces heme oxygenase-1 expression in multiple myeloma.

Journal: Cell cycle (Georgetown, Tex.) 20120615

Title: Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

Journal: The Cochrane database of systematic reviews 20120613

Title: Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma.

Journal: Cancer cell 20120612

Title: Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis.

Journal: Blood 20120607

Title: Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.

Journal: Blood 20120607

Title: A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis.

Journal: Blood 20120607

Title: Haematological cancer: Lenalidomide maintenance--perils of a premature denouement.

Journal: Nature reviews. Clinical oncology 20120605

Title: [The thalidomide experience: review of its effects 50 years later].

Journal: Medicina clinica 20120602

Title: Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.

Journal: European journal of radiology 20120601

Title: Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma.

Journal: American journal of clinical oncology 20120601

Title: Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.

Journal: Medical oncology (Northwood, London, England) 20120601

Title: Reversible pulmonary toxicity due to lenalidomide.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601

Title: Novel agents-based regimens as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.

Journal: Hematological oncology 20120601

Title: Clinical response to thalidomide and colchicine in two siblings with Behcet's disease carrying a single mutated MEFV allele.

Journal: Rheumatology international 20120601

Title: Thalidomide delayed the ability of 4T1 cells to amass into tumors in Balb/c mice.

Journal: Immunopharmacology and immunotoxicology 20120601

Title: Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.

Journal: The Prostate 20120601

Title: Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Journal: Bone marrow transplantation 20120601

Title: Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120601

Title: Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide.

Journal: Journal of gastroenterology and hepatology 20120601

Title: Progressive neurological deficits in multiple myeloma: meningeal myelomatosis without MRI abnormalities.

Journal: Journal of neurology 20120601

Title: Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulation.

Journal: Leukemia 20120601

Title: A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes.

Journal: Leukemia research 20120601

Title: Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers.

Journal: Clinical lymphoma, myeloma & leukemia 20120601

Title: Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients.

Journal: European journal of haematology 20120601

Title: Phase II trial of syncopated thalidomide, lenalidomide, and weekly dexamethasone in patients with newly diagnosed multiple myeloma.

Journal: Clinical lymphoma, myeloma & leukemia 20120601

Title: Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.

Journal: Angiogenesis 20120601

Title: Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study.

Journal: European journal of haematology 20120601

Title: Preclinical predictors of anticancer drug efficacy: critical assessment with emphasis on whether nanomolar potency should be required of candidate agents.

Journal: The Journal of pharmacology and experimental therapeutics 20120601

Title: Therapy with lenalidomide plus dexamethasone-induced bone formation in a patient with refractory multiple myeloma.

Journal: International journal of hematology 20120601

Title: SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma.

Journal: Annals of hematology 20120601

Title: Multiple myeloma-associated iliopsoas muscular amyloidoma first presenting with bilateral femoral nerve entrapment.

Journal: International journal of hematology 20120601

Title: Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.

Journal: American journal of hematology 20120601

Title: Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120601

Title: Elotuzumab in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120601

Title: Lenalidomide in solid tumors.

Journal: Cancer chemotherapy and pharmacology 20120601

Title: Immunotherapy for tuberculosis: what's the better choice?

Journal: Frontiers in bioscience (Landmark edition) 20120601

Title: The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).

Journal: Best practice & research. Clinical haematology 20120601

Title: Autologous transplantation and management of younger patients with mantle cell lymphoma.

Journal: Best practice & research. Clinical haematology 20120601

Title: Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value.

Journal: Expert review of anticancer therapy 20120601

Title: Lenalidomide maintenance for multiple myeloma.

Journal: The Lancet. Oncology 20120601

Title: Adaptive toothbrush handle: case report of a Thalidomide patient.

Journal: The European journal of prosthodontics and restorative dentistry 20120601

Title: [Teleangiectasia hereditaria haemorrhagica--Osler-Weber-Rendu syndrome. Case study and treatment experience].

Journal: Vnitrni lekarstvi 20120601

Title: Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.

Journal: Blood 20120524

Title: [Effects of tea polyphenols on the expression of NF-κB, COX-2 and survivin in Lewis lung carcinoma xenografts in C57BL/6 mice].

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520

Title: Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study.

Journal: Blood 20120517

Title: Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma.

Journal: Blood 20120510

Title: Continuous lenalidomide treatment for newly diagnosed multiple myeloma.

Journal: The New England journal of medicine 20120510

Title: Lenalidomide after stem-cell transplantation for multiple myeloma.

Journal: The New England journal of medicine 20120510

Title: Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Journal: The New England journal of medicine 20120510

Title: Lenalidomide in myeloma--a high-maintenance friend.

Journal: The New England journal of medicine 20120510

Title: Novel molecular targeted therapies for refractory thyroid cancer.

Journal: Head & neck 20120501

Title: A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q - myelodysplastic syndromes.

Journal: Leukemia & lymphoma 20120501

Title: Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1).

Journal: Thrombosis research 20120501

Title: Effect of immunomodulating medications in complex regional pain syndrome: a systematic review.

Journal: The Clinical journal of pain 20120501

Title: Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia.

Journal: Leukemia 20120501

Title: Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies.

Journal: Leukemia 20120501

Title: Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide.

Journal: Leukemia & lymphoma 20120501

Title: Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma.

Journal: European journal of clinical pharmacology 20120501

Title: Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial.

Journal: Haematologica 20120501

Title: Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study.

Journal: Leukemia research 20120501

Title: Long-term transfusion independence in del(5q) MDS patients after short term therapy with lenalidomide: 2 new cases.

Journal: Leukemia research 20120501

Title: Clinical experience with thalidomide and lenalidomide in multiple myeloma.

Journal: Current cancer drug targets 20120501

Title: Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20120501

Title: Recent developments in treatments targeting castration-resistant prostate cancer bone metastases.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120501

Title: Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia.

Journal: British journal of haematology 20120501

Title: The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.

Journal: European journal of haematology 20120501

Title: Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats.

Journal: Neurochemical research 20120501

Title: In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma.

Journal: Leukemia research 20120501

Title: Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.

Journal: American journal of hematology 20120501

Title: Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.

Journal: British journal of haematology 20120501

Title: Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?

Journal: Current opinion in rheumatology 20120501

Title: Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium.

Journal: American journal of hematology 20120501

Title: Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management.

Journal: American journal of hematology 20120501

Title: Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.

Journal: Journal of drugs in dermatology : JDD 20120501

Title: [Current approaches in multiple myeloma and other cancer-related bone diseases].

Journal: Deutsche medizinische Wochenschrift (1946) 20120501

Title: European perspective on multiple myeloma treatment strategies: update following recent congresses.

Journal: The oncologist 20120501

Title: Prediction of drug-target interactions and drug repositioning via network-based inference.

Journal: PLoS computational biology 20120501

Title: Multiple myeloma: myeloablative therapy with autologous stem cell support versus chemotherapy: a meta-analysis.

Journal: Anticancer research 20120501

Title: Lenalidomide: second cancers.

Journal: Prescrire international 20120501

Title: [The potential pathogenesis of gastrointestinal vascular malformation and the potential mechanism of thalidomide in the treatment of gastrointestinal vascular malformation].

Journal: Zhonghua nei ke za zhi 20120501

Title: The thalidomide analgesic effect is associated with differential TNF-α receptor expression in the dorsal horn of the spinal cord as studied in a rat model of neuropathic pain.

Journal: Brain research 20120423

Title: Thalidomide for managing cancer cachexia.

Journal: The Cochrane database of systematic reviews 20120418

Title: [A case report of undifferentiated connective tissue disease associated myelodysplastic].

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20120418

Title: Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120415

Title: [AL amyloidosis].

Journal: Orvosi hetilap 20120415

Title: Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib.

Journal: Rare tumors 20120412

Title: In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines.

Journal: Investigational new drugs 20120401

Title: Indeterminate cell histiocytosis in a pediatric patient: successful treatment with thalidomide.

Journal: Pathology oncology research : POR 20120401

Title: Donor cell leukaemia after allogeneic haematopoietic SCT followed by prolonged thalidomide maintenance for multiple myeloma.

Journal: Bone marrow transplantation 20120401

Title: Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population.

Journal: Pathology oncology research : POR 20120401

Title: Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.

Journal: The Prostate 20120401

Title: Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120401

Title: Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare.

Journal: Journal of the American Academy of Dermatology 20120401

Title: Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.

Journal: Critical reviews in oncology/hematology 20120401

Title: IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes.

Journal: Leukemia 20120401

Title: Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide.

Journal: Leukemia 20120401

Title: Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy.

Journal: Leukemia 20120401

Title: Interest of the association azacitidine-lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype.

Journal: Leukemia 20120401

Title: Bisphosphonates as antimyeloma drugs.

Journal: Leukemia 20120401

Title: Lenalidomide in multiple myeloma: current experimental and clinical data.

Journal: European journal of haematology 20120401

Title: Thalidomide treatment in cirrhotic patients with severe anemia secondary to vascular malformations.

Journal: Digestive diseases and sciences 20120401

Title: Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.

Journal: Cancer chemotherapy and pharmacology 20120401

Title: Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates.

Journal: Cancer chemotherapy and pharmacology 20120401

Title: Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats.

Journal: Inflammopharmacology 20120401

Title: Management of treatment-emergent peripheral neuropathy in multiple myeloma.

Journal: Leukemia 20120401

Title: Establishing Rps6 hemizygous mice as a model for studying how ribosomal protein haploinsufficiency impairs erythropoiesis.

Journal: Experimental hematology 20120401

Title: Lower dose dexamethasone/thalidomide and zoledronic acid every 3 weeks in previously untreated multiple myeloma.

Journal: Clinical lymphoma, myeloma & leukemia 20120401

Title: Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Journal: Endocrine 20120401

Title: Treating Graves' orbitopathy: where are we?

Journal: Endocrine 20120401

Title: Perinephric extramedullary haematopoiesis in primary myelofibrosis.

Journal: British journal of haematology 20120401

Title: Automatic filtering and substantiation of drug safety signals.

Journal: PLoS computational biology 20120401

Title: Multiple myeloma: treatment evolution.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Breakthroughs in myeloproliferative neoplasms.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: New developments in the management of diffuse large B-cell lymphoma.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Frontline treatment of multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Novel therapeutics in multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Stem cell transplantation for multiple myeloma: current and future status.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Novel therapies in monoclonal gammopathies.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Targeted therapy of multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Thrombosis in multiple myeloma (MM).

Journal: Hematology (Amsterdam, Netherlands) 20120401

Title: Current status of targeted therapy for advanced renal cell carcinoma.

Journal: Korean journal of urology 20120401

Title: [Clinical observation of thalidomide combined with VAD regimen for treatment of osteosclerotic myeloma (POEMS syndrome)].

Journal: Zhongguo shi yan xue ye xue za zhi 20120401

Title: Temozolomide in aggressive pituitary adenomas and carcinomas.

Journal: Clinics (Sao Paulo, Brazil) 20120401

Title: Thromboprophylaxis in non-surgical cancer patients.

Journal: Thrombosis research 20120401

Title: [Immunomodulatory drugs in the treatment of primary systemic light chain amyloidosis].

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20120401

Title: IMWG consensus on maintenance therapy in multiple myeloma.

Journal: Blood 20120329

Title: A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide.

Journal: Blood 20120322

Title: A short story of anti-rheumatic therapy. VIII. The immunodepressants.

Journal: Reumatismo 20120319

Title: Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response.

Journal: Cancer 20120315

Title: Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients.

Journal: Cancer 20120315

Title: Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.

Journal: Cancer research 20120315

Title: Effect of a patient support program on access to oral therapy for hematologic malignancies.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120315

Title: Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.

Journal: British journal of cancer 20120313

Title: Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo.

Journal: Bone marrow transplantation 20120301

Title: Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro.

Journal: Hematological oncology 20120301

Title: Lenalidomide is active for extramedullary disease in refractory multiple myeloma.

Journal: Annals of hematology 20120301

Title: Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options.

Journal: Hematological oncology 20120301

Title: Distinct clonal deletions of the long arm of chromosome 5 in a patient with myelodysplastic syndrome.

Journal: Leukemia & lymphoma 20120301

Title: Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma 20120301

Title: Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma.

Journal: Annals of hematology 20120301

Title: Lepromatous leprosy presenting as an acute polyarthritis in a Colombian immigrant in Spain.

Journal: Joint, bone, spine : revue du rhumatisme 20120301

Title: Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.

Journal: The British journal of dermatology 20120301

Title: Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.

Journal: Clinical and experimental dermatology 20120301

Title: Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.

Journal: European journal of haematology 20120301

Title: Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects.

Journal: Cancer chemotherapy and pharmacology 20120301

Title: Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers.

Journal: Haematologica 20120301

Title: Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.

Journal: Haematologica 20120301

Title: A review of supernumerary and absent limbs and digits of the upper limb.

Journal: Surgical and radiologic anatomy : SRA 20120301

Title: Lenalidomide proved effective in multisystem Langerhans cell histiocytosis.

Journal: Acta oncologica (Stockholm, Sweden) 20120301

Title: Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma.

Journal: Leukemia & lymphoma 20120301

Title: Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-β-cyclodextrin complexes.

Journal: AAPS PharmSciTech 20120301

Title: Hematologic malignancies and thrombosis.

Journal: Thrombosis research 20120301

Title: Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301

Title: Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents.

Journal: British journal of haematology 20120301

Title: Drug interaction between lenalidomide and itraconazole.

Journal: American journal of hematology 20120301

Title: Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.

Journal: Alimentary pharmacology & therapeutics 20120301

Title: Soft tissue and subcutaneous calcification in connective tissue diseases.

Journal: Current opinion in rheumatology 20120301

Title: Immune reconstitution in chronic lymphocytic leukemia.

Journal: Current hematologic malignancy reports 20120301

Title: Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120301

Title: Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function.

Journal: Blood 20120301

Title: Update on the use of defibrotide.

Journal: Expert opinion on biological therapy 20120301

Title: Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies.

Journal: Expert opinion on pharmacotherapy 20120301

Title: Human teratogens update 2011: can we ensure safety during pregnancy?

Journal: Birth defects research. Part A, Clinical and molecular teratology 20120301

Title: Propylthiouracil-induced ANCA-positive erythema nodosum treated with thalidomide.

Journal: International journal of dermatology 20120301

Title: Deciphering the mystery of thalidomide teratogenicity.

Journal: Congenital anomalies 20120301

Title: Thromboprophylaxis in multiple myeloma: is the evidence there?

Journal: Expert review of anticancer therapy 20120301

Title: Classification and surgical treatment of symphalangism in interphalangeal joints of the hand.

Journal: Clinics in orthopedic surgery 20120301

Title: Advances in the treatment of relapsed or refractory Hodgkin's lymphoma.

Journal: The oncologist 20120301

Title: A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.

Journal: Journal of drugs in dermatology : JDD 20120301

Title: [New therapeutic targets in psoriatic arthritis].

Journal: Reumatologia clinica 20120301

Title: Bendamustine: inadequate or outdated data.

Journal: Prescrire international 20120301

Title: Thalidomide and lenalidomide: overview of the French pharmacovigilance database.

Journal: Prescrire international 20120301

Title: Sclerosing mesenteritis as an unusual cause of fever of unknown origin: a case report and review.

Journal: Clinics (Sao Paulo, Brazil) 20120301

Title: Cellular immunotherapy using dendritic cells against multiple myeloma.

Journal: The Korean journal of hematology 20120301

Title: Latest advances and current challenges in the treatment of multiple myeloma.

Journal: Nature reviews. Clinical oncology 20120221

Title: Adamantiades-Behcet's disease-complicated gastroenteropathy.

Journal: World journal of gastroenterology 20120221

Title: Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.

Journal: AIDS (London, England) 20120220

Title: In vivo formation of dihydroxylated and glutathione conjugate metabolites derived from thalidomide and 5-Hydroxythalidomide in humanized TK-NOG mice.

Journal: Chemical research in toxicology 20120220

Title: Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120220

Title: Unmet challenges in the use of novel agents in locally advanced non-small-cell lung cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120220

Title: [Myelodysplastic syndrome in the elderly: comprehensive geriatric assessment and therapeutic recommendations].

Journal: Medicina clinica 20120218

Title: Targeted therapy for chronic lymphocytic leukemia: a glimpse into the future.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120210

Title: Thalidomide-based multidisciplinary treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis.

Journal: World journal of gastroenterology 20120207

Title: Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.

Journal: Investigational new drugs 20120201

Title: Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma.

Journal: International journal of radiation oncology, biology, physics 20120201

Title: Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.

Journal: Annals of hematology 20120201

Title: Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120201

Title: (Therapy-related?) large bowel acute ischemia in thalidomide-treated patient.

Journal: International journal of colorectal disease 20120201

Title: Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion.

Journal: Annals of hematology 20120201

Title: Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma.

Journal: Annals of hematology 20120201

Title: The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine.

Journal: Lung cancer (Amsterdam, Netherlands) 20120201

Title: Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.

Journal: Annals of hematology 20120201

Title: Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide.

Journal: Leukemia 20120201

Title: Genomic stratification of multiple myeloma treated with novel agents.

Journal: Leukemia & lymphoma 20120201

Title: High prevalence of hepatitis B virus infection in multiple myeloma.

Journal: Leukemia & lymphoma 20120201

Title: Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease.

Journal: Leukemia & lymphoma 20120201

Title: A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas.

Journal: Journal of neuro-oncology 20120201

Title: Genetic variations in multiple myeloma II: association with effect of treatment.

Journal: European journal of haematology 20120201

Title: Thrombotic complications in multiple myeloma: a report of three cases and review of the literature.

Journal: Journal of thrombosis and thrombolysis 20120201

Title: Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma.

Journal: British journal of haematology 20120201

Title: Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies.

Journal: Haematologica 20120201

Title: Angiosarcoma of the liver with metastasis to the cervical spine cured with the treatment of thalidomide and radiotherapy.

Journal: Acta neurochirurgica 20120201

Title: Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201

Title: Efficacy and safety of apremilast in chronic cutaneous sarcoidosis.

Journal: Archives of dermatology 20120201

Title: Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal.

Journal: Clinical lymphoma, myeloma & leukemia 20120201

Title: POEMS syndrome with severe neurological damage clinically recovered with lenalidomide.

Journal: Haematologica 20120201

Title: A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.

Journal: British journal of haematology 20120201

Title: The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.

Journal: Apoptosis : an international journal on programmed cell death 20120201

Title: Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients.

Journal: Journal of cancer research and clinical oncology 20120201

Title: How to manage neutropenia in multiple myeloma.

Journal: Clinical lymphoma, myeloma & leukemia 20120201

Title: Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.

Journal: International journal of hematology 20120201

Title: Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours.

Journal: Endocrine-related cancer 20120201

Title: Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication.

Journal: Journal of viral hepatitis 20120201

Title: Lenalidomide alone or lenalidomide plus dexamethasone significantly inhibit IgG and IgM in vitro... A possible explanation for their mechanism of action in treating multiple myeloma.

Journal: International immunopharmacology 20120201

Title: p53 nuclear expression correlates with hemizygous TP53 deletion and predicts an adverse outcome for patients with relapsed/refractory multiple myeloma treated with lenalidomide.

Journal: American journal of clinical pathology 20120201

Title: Thalidomide and its analogs for hemoglobinopathies: two birds with one stone?

Journal: Expert review of hematology 20120201

Title: Management of myeloma-associated renal dysfunction in the era of novel therapies.

Journal: Expert review of hematology 20120201

Title: Emerging novel therapies for advanced prostate cancer.

Journal: Therapeutic advances in urology 20120201

Title: Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias.

Journal: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20120201

Title: Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1.

Journal: Oncotarget 20120201

Title: [Lenalidomide in hematological malignancies---review].

Journal: Zhongguo shi yan xue ye xue za zhi 20120201

Title: Thalidomide: deafness.

Journal: Prescrire international 20120201

Title: [Multiple myeloma].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20120201

Title: [B-cell acute lymphoblastic leukemia developed 5 years after autologous stem cell transplantation for multiple myeloma].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20120201

Title: [Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].

Journal: Vnitrni lekarstvi 20120201

Title: Immunoglobulin light-chain amyloidosis: growing recognition, new approaches to therapy, active clinical trials.

Journal: Oncology (Williston Park, N.Y.) 20120201

Title: Myelodysplastic syndromes: a challenging disease for patients and physicians.

Journal: The Journal of the Association of Physicians of India 20120201

Title: Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.

Journal: Blood 20120126

Title: β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression.

Journal: Oncogene 20120119

Title: Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.

Journal: Cancer 20120115

Title: Comparison of the predictive ability of several second-order multivariate methods in the simultaneous determination of two therapeutic drugs in human urine.

Journal: Talanta 20120115

Title: [Case report: Reversible posterior leukoencephalopathy associated with the treatment of multiple myeloma: a case report].

Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20120110

Title: The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

Journal: Blood 20120105

Title: M(yeloma)IXing up T maintenance.

Journal: Blood 20120105

Title: Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?

Journal: British journal of cancer 20120103

Title: Large-cell neuroendocrine carcinoma of the cervix.

Journal: Rare tumors 20120102

Title: Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.

Journal: Rheumatology international 20120101

Title: Impact of response to thalidomide-, lenalidomide- or bortezomib- containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation.

Journal: Bone marrow transplantation 20120101

Title: Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.

Journal: Annals of hematology 20120101

Title: International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents.

Journal: Annals of hematology 20120101

Title: A Phase II dose titration study of thalidomide for cancer-associated anorexia.

Journal: Journal of pain and symptom management 20120101

Title: Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab.

Journal: Journal of pediatric gastroenterology and nutrition 20120101

Title: Defibrotide blunts the prothrombotic effect of thalidomide on endothelial cells.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20120101

Title: Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.

Journal: Journal of oncology 20120101

Title: Depressive-like behavior induced by tumor necrosis factor-α in mice.

Journal: Neuropharmacology 20120101

Title: Targeting the tumor microenvironment: focus on angiogenesis.

Journal: Journal of oncology 20120101

Title: Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application.

Journal: Journal of oncology 20120101

Title: Tumor blood vessel 'normalization' improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.

Journal: Radiation research 20120101

Title: The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.

Journal: European journal of haematology 20120101

Title: Lack of efficacy of combined antiangiogenic therapies in xenografted human melanoma.

Journal: Journal of oncology 20120101

Title: New Evidence-Based Treatment Approach in Behçet's Disease.

Journal: Pathology research international 20120101

Title: Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents.

Journal: Leukemia 20120101

Title: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Journal: Gut 20120101

Title: The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes.

Journal: Expert opinion on drug safety 20120101

Title: Long-term outcome of pomalidomide therapy in myelofibrosis.

Journal: American journal of hematology 20120101

Title: [Observational retrospective study to evaluate the effectiveness and safety of treatment schemes with bortezomib for multiple myeloma in our hospital].

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101

Title: Angiogenesis in head and neck cancer: a review of the literature.

Journal: Journal of oncology 20120101

Title: Use of cyclosporine in uterine transplantation.

Journal: Journal of transplantation 20120101

Title: Tuberculosis in pregnancy: a review.

Journal: Journal of pregnancy 20120101

Title: Stability of an extemporaneously prepared thalidomide suspension.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120101

Title: Signaling required for blood vessel maintenance: molecular basis and pathological manifestations.

Journal: International journal of vascular medicine 20120101

Title: Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.

Journal: Virology journal 20120101

Title: Multiple myeloma presenting as acute tubulointerstitial nephritis and normal serum protein electrophoresis.

Journal: Iranian journal of kidney diseases 20120101

Title: Vitamins A & D inhibit the growth of mycobacteria in radiometric culture.

Journal: PloS one 20120101

Title: Systemic arthritis in children: a review of clinical presentation and treatment.

Journal: International journal of inflammation 20120101

Title: Imaging features of therapeutic drug-induced musculoskeletal abnormalities.

Journal: Radiographics : a review publication of the Radiological Society of North America, Inc 20120101

Title: Advantageous use of lenalidomide in multiple myeloma: discussion of three case studies.

Journal: Current opinion in oncology 20120101

Title: Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.

Journal: Current opinion in oncology 20120101

Title: Safety and efficacy of lenalidomide in relapsed or refractory multiple myeloma.

Journal: Clinical Medicine Insights. Oncology 20120101

Title: TGFβ signaling and cardiovascular diseases.

Journal: International journal of biological sciences 20120101

Title: Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.

Journal: The Netherlands journal of medicine 20120101

Title: Challenges to physician-patient communication about medication use: a window into the skeptical patient's world.

Journal: Patient preference and adherence 20120101

Title: Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma.

Journal: PloS one 20120101

Title: TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.

Journal: Journal of neuroinflammation 20120101

Title: Treatment for primary hypothyroidism: current approaches and future possibilities.

Journal: Drug design, development and therapy 20120101

Title: Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy.

Journal: Clinical, cosmetic and investigational dermatology 20120101

Title: Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma.

Journal: Oncology 20120101

Title: Multi-parametric profiling network based on gene expression and phenotype data: a novel approach to developmental neurotoxicity testing.

Journal: International journal of molecular sciences 20120101

Title: Oncolytic virotherapy for hematological malignancies.

Journal: Advances in virology 20120101

Title: Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model.

Journal: PloS one 20120101

Title: Institutional review board (IRB) and ethical issues in clinical research.

Journal: Korean journal of anesthesiology 20120101

Title: New treatment options for lupus - a focus on belimumab.

Journal: Therapeutics and clinical risk management 20120101

Title: Skin manifestations of inflammatory bowel disease.

Journal: Frontiers in physiology 20120101

Title: Neovascular niche for human myeloma cells in immunodeficient mouse bone.

Journal: PloS one 20120101

Title: Unrecognized bomb hidden in the babies' room: fatal pulmonary damage related with use of biocide in humidifiers.

Journal: Environmental health and toxicology 20120101

Title: [Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall].

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20120101

Title: A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis.

Journal: PloS one 20120101

Title: Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer.

Journal: PloS one 20120101

Title: [MDS].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20120101

Title: IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy.

Journal: Journal of experimental & clinical cancer research : CR 20120101

Title: Influence of cytochrome P450 2C19 gene variations on pharmacokinetic parameters of thalidomide in Japanese patients.

Journal: Biological & pharmaceutical bulletin 20120101

Title: [Safety assessment of nanomaterials in reproductive developmental field].

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101

Title: Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.

Journal: PloS one 20120101

Title: Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.

Journal: Journal of hematology & oncology 20120101

Title: Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.

Journal: Pharmacotherapy 20120101

Title: Ruxolitinib for the treatment of myelofibrosis: its clinical potential.

Journal: Therapeutics and clinical risk management 20120101

Title: Microenvironment-centred dynamics in aggressive B-cell lymphomas.

Journal: Advances in hematology 20120101

Title: JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms.

Journal: Advances in hematology 20120101

Title: The JNK inhibitor XG-102 protects against TNBS-induced colitis.

Journal: PloS one 20120101

Title: Genotyping performance between saliva and blood-derived genomic DNAs on the DMET array: a comparison.

Journal: PloS one 20120101

Title: [Children with thalidomide injuries are still being born].

Journal: Lakartidningen 20120101

Title: [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].

Journal: Vnitrni lekarstvi 20120101

Title: [A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide].

Journal: Rinsho shinkeigaku = Clinical neurology 20120101

Title: Neuroinflammation in the aging down syndrome brain; lessons from Alzheimer's disease.

Journal: Current gerontology and geriatrics research 20120101

Title: Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Journal: Cancer management and research 20120101

Title: State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.

Journal: Clinical Medicine Insights. Oncology 20120101

Title: Twenty two cases of canine neural angiostronglyosis in eastern Australia (2002-2005) and a review of the literature.

Journal: Parasites & vectors 20120101

Title: Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.

Journal: Clinical & developmental immunology 20120101

Title: Immunotherapy using dendritic cells against multiple myeloma: how to improve?

Journal: Clinical & developmental immunology 20120101

Title: Animal Models in Behçet's Disease.

Journal: Pathology research international 20120101

Title: [A rare cause of hyperamylasemia].

Journal: Annales de biologie clinique 20120101

Title: Generating aptamers by cell-SELEX for applications in molecular medicine.

Journal: International journal of molecular sciences 20120101

Title: The role of regulatory T cells and TH17 cells in multiple myeloma.

Journal: Clinical & developmental immunology 20120101

Title: Glutathione homeostasis and functions: potential targets for medical interventions.

Journal: Journal of amino acids 20120101

Title: Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling.

Journal: PloS one 20120101

Title: Leptin in anorexia and cachexia syndrome.

Journal: International journal of peptides 20120101

Title: A multimodal approach to the management of neuroendocrine tumour liver metastases.

Journal: International journal of hepatology 20120101

Title: Brain metastases from endometrial carcinoma.

Journal: ISRN oncology 20120101

Title: Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.

Journal: PloS one 20120101

Title: DNA aptamers against the Lup an 1 food allergen.

Journal: PloS one 20120101

Title: Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.

Journal: PloS one 20120101

Title: Castration-resistant prostate cancer: mechanisms, targets, and treatment.

Journal: Prostate cancer 20120101

Title: Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.

Journal: ISRN pharmacology 20120101

Title: Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.

Journal: Journal of thyroid research 20120101

Title: [Prognostic significance of morphology in multiple myeloma].

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20120101

Title: Update on treatment of follicular non-Hodgkin's lymphoma: focus on potential of bortezomib.

Journal: Patient preference and adherence 20120101

Title: Novel therapies for aggressive B-cell lymphoma.

Journal: Advances in hematology 20120101

Title: Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence.

Journal: PloS one 20120101

Title: Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.

Journal: PloS one 20120101

Title: POEMS Syndrome: A Report of 14 Cases and Review of the Literature.

Journal: ISRN gastroenterology 20120101

Title: Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS).

Journal: Journal of hematology & oncology 20120101

Title: Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?

Journal: Clinical Medicine Insights. Oncology 20120101

Title: Embryonic stem cells: An alternative approach to developmental toxicity testing.

Journal: Journal of pharmacy & bioallied sciences 20120101

Title: Adult male with multiple cranial nerve palsies.

Journal: Annals of Indian Academy of Neurology 20120101

Title: Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.

Journal: Clinical & developmental immunology 20120101

Title: Cerebral vein thrombosis misdiagnosed and mismanaged.

Journal: Thrombosis 20120101

Title: Lucio's phenomenon: another case reported in Brazil.

Journal: Anais brasileiros de dermatologia 20120101

Title: The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy.

Journal: Therapeutics and clinical risk management 20120101

Title: Lenalidomide for treatment of myelodysplastic syndromes.

Journal: Current pharmaceutical design 20120101

Title: Approach to new therapeutics: investigation by the use of MDS-derived cell lines.

Journal: Current pharmaceutical design 20120101

Title: Drug-induced interstitial pneumonitis due to low-dose lenalidomide.

Journal: Internal medicine (Tokyo, Japan) 20120101

Title: The role of radiation therapy in the management of metastatic melanoma in the brain.

Journal: International journal of surgical oncology 20120101

Title: Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-κB/JNK.

Journal: International journal of molecular sciences 20120101

Title: Immunogenic targets for specific immunotherapy in multiple myeloma.

Journal: Clinical & developmental immunology 20120101

Title: Gestational valproate alters BOLD activation in response to complex social and primary sensory stimuli.

Journal: PloS one 20120101

Title: Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.

Journal: PloS one 20120101

Title: 'Malignant' perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

Journal: Sarcoma 20120101

Title: Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330.

Journal: Sarcoma 20120101

Title: Progress towards mechanism-based treatment for Diamond-Blackfan anemia.

Journal: TheScientificWorldJournal 20120101

Title: Prognostic significance of serum proangiogenic molecules in patients with de novo non-Hodgkin lymphomas.

Journal: TheScientificWorldJournal 20120101

Title: Prognostic value of hepatocyte growth factor, syndecan-1, and osteopontin in multiple myeloma and monoclonal gammopathy of undetermined significance.

Journal: TheScientificWorldJournal 20120101

Title: Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model.

Journal: PloS one 20120101

Title: Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease.

Journal: Journal of neuroinflammation 20120101

Title: Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.

Journal: Clinical & developmental immunology 20120101

Title: Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease.

Journal: Frontiers in oncology 20120101

Title: Thalidomide: chemistry, therapeutic potential and oxidative stress induced teratogenicity.

Journal: Current topics in medicinal chemistry 20120101

Title: TNF α signaling beholds thalidomide saga: a review of mechanistic role of TNF-α signaling under thalidomide.

Journal: Current topics in medicinal chemistry 20120101

Title: Effects of thalidomide on the development of bone damage caused by prednisolone in rats.

Journal: Pharmacological reports : PR 20120101

Title: Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy.

Journal: Frontiers in pharmacology 20120101

Title: Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma.

Journal: PloS one 20120101

Title: PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report.

Journal: Case reports in oncology 20120101

Title: Emerging targeted therapies for castration-resistant prostate cancer.

Journal: Frontiers in endocrinology 20120101

Title: Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent.

Journal: PloS one 20120101

Title: Developmental toxicology: methods and protocols. Volume overview: introduction.

Journal: Methods in molecular biology (Clifton, N.J.) 20120101

Title: Plasma cell myeloma associated with Epstein-Barr virus infection in an 11-year-old girl.

Journal: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 20120101

Title: Ulcerative Necrobiosis Lipoidica: Is There a Place for Anti-TNFα Treatment?

Journal: Case reports in medicine 20120101

Title: Autologous stem cell transplant for Al amyloidosis.

Journal: Bone marrow research 20120101

Title: Curability of multiple myeloma.

Journal: Bone marrow research 20120101

Title: Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation.

Journal: International journal of nanomedicine 20120101

Title: Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD.

Journal: Journal of hematology & oncology 20120101

Title: An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Journal: Case reports in medicine 20120101

Title: Isolated facial cutaneous sarcoidosis.

Journal: Journal of natural science, biology, and medicine 20120101

Title: Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma.

Journal: Cancer management and research 20120101

Title: Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.

Journal: Advances in hematology 20120101

Title: Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation.

Journal: Bone marrow research 20120101

Title: A framework to identify gene expression profiles in a model of inflammation induced by lipopolysaccharide after treatment with thalidomide.

Journal: BMC research notes 20120101

Title: Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.

Journal: Stem cells international 20120101

Title: Leukocytoclastic vasculitis: a window to systemic churg strauss syndrome.

Journal: Indian journal of dermatology 20120101

Title: Bortezomib a safe treatment for patients with multiple myeloma and cystic fibrosis.

Journal: Mediterranean journal of hematology and infectious diseases 20120101

Title: Potential inhibitory effect of LASSBio-596, a new thalidomide hybrid, on inflammatory corneal angiogenesis in rabbits.

Journal: Ophthalmic research 20120101

Title: Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRI.

Journal: PloS one 20120101

Title: Lenalidomide in the treatment of young patients with multiple myeloma: from induction to consolidation/maintenance therapy.

Journal: Advances in hematology 20120101

Title: Multitargeted treatment of cancer cachexia.

Journal: Critical reviews in oncogenesis 20120101

Title: Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.

Journal: BMC cancer 20120101

Title: Long-term disease stabilization in a patient with castration-resistant metastatic prostate cancer by the addition of lenalidomide to low-dose dexamethasone and celecoxib.

Journal: Onkologie 20120101

Title: Molecular action of lenalidomide in lymphocytes and hematologic malignancies.

Journal: Advances in hematology 20120101

Title: Brazilian blood donation eligibility criteria for dermatologic patients.

Journal: Anais brasileiros de dermatologia 20120101

Title: Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma.

Journal: Advances in hematology 20120101

Title: Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.

Journal: International journal of clinical and experimental pathology 20120101

Title: Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells.

Journal: PloS one 20120101

Title: Lenalidomide for the treatment of relapsed and refractory multiple myeloma.

Journal: Cancer management and research 20120101

Title: Emerging strategies for targeting cell adhesion in multiple myeloma.

Journal: Advances in pharmacology (San Diego, Calif.) 20120101

Title: Nitric oxide rescues thalidomide mediated teratogenicity.

Journal: Scientific reports 20120101

Title: Safety and observations in a pilot study of lenalidomide for treatment in autism.

Journal: Autism research and treatment 20120101

Title: Attainment of a stringent complete response in multiple myeloma with thalidomide monotherapy.

Journal: Internal medicine (Tokyo, Japan) 20120101

Title: Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy.

Journal: Anais brasileiros de dermatologia 20120101

Title: Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma.

Journal: OncoTargets and therapy 20120101

Title: Toxicity of autologous hematopoietic cell transplantation in patients with multiple myeloma - comparison between two different induction regimens.

Journal: Clinical transplantation 20120101

Title: Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma.

Journal: PloS one 20120101

Title: Unexpected remission of hepatocellular carcinoma (HCC) with lung metastasis to the combination therapy of thalidomide and cyproheptadine: report of two cases and a preliminary HCC cell line study.

Journal: BMJ case reports 20120101

Title: [Maintenance therapies of thalidomine and interferon-α in multiple myeloma].

Journal: Zhonghua yi xue za zhi 20111227

Title: Drugs: More shots on target.

Journal: Nature 20111214

Title: IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.

Journal: Blood 20111208

Title: Learning about the safety of drugs--a half-century of evolution.

Journal: The New England journal of medicine 20111208

Title: Myeloma and second primary cancers.

Journal: The New England journal of medicine 20111208

Title: Effect of combined dexamethasone/lenalidomide therapy on NK cell-receptor levels in myeloma patients.

Journal: Blood 20111208

Title: Thalidomide induces mucosal healing in Crohn's disease: case report.

Journal: World journal of gastroenterology 20111207

Title: Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells.

Journal: Melanoma research 20111201

Title: Cutaneous lupus erythematosus: update of therapeutic options part II.

Journal: Journal of the American Academy of Dermatology 20111201

Title: Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma.

Journal: Annals of hematology 20111201

Title: Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.

Journal: Annals of hematology 20111201

Title: t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.

Journal: Cancer chemotherapy and pharmacology 20111201

Title: Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial.

Journal: Annals of hematology 20111201

Title: A prospective clinical trial of lenalidomide with topotecan in women with advanced epithelial ovarian carcinoma.

Journal: International journal of clinical oncology 20111201

Title: Preclinical development of siRNA therapeutics for AL amyloidosis.

Journal: Gene therapy 20111201

Title: Cytokine modulators in the treatment of sarcoidosis.

Journal: Rheumatology international 20111201

Title: Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease.

Journal: British journal of haematology 20111201

Title: Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.

Journal: Leukemia 20111201

Title: [Leukocytoclastic vasculitis related to cocaine use].

Journal: Actas dermo-sifiliograficas 20111201

Title: Multiple myeloma associated IgA pemphigus: treatment with bortezomib- and lenalidomide-based regimen.

Journal: Clinical lymphoma, myeloma & leukemia 20111201

Title: Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration.

Journal: Xenobiotica; the fate of foreign compounds in biological systems 20111201

Title: Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.

Journal: Clinical lymphoma, myeloma & leukemia 20111201

Title: The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients.

Journal: Cancer chemotherapy and pharmacology 20111201

Title: Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.

Journal: Neuro-oncology 20111201

Title: Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

Journal: Blood 20111201

Title: Upregulated expression of the PSMB5 gene may contribute to drug resistance in patient with multiple myeloma when treated with bortezomib-based regimen.

Journal: Experimental hematology 20111201

Title: Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.

Journal: The Lancet. Oncology 20111201

Title: The 5q- syndrome: biology and treatment.

Journal: Current treatment options in oncology 20111201

Title: [Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases].

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20111201

Title: Thalidomide in the treatment of psoriasis vulgaris: a pilot study.

Journal: The Journal of dermatology 20111201

Title: Behçet disease: clinical features and management in a Brazilian tertiary hospital.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20111201

Title: Treating chronic lymphocytic leukemia with thalidomide and lenalidomide.

Journal: Expert opinion on pharmacotherapy 20111201

Title: Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide.

Journal: International journal of hematology 20111201

Title: Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens.

Journal: Leukemia & lymphoma 20111201

Title: The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.

Journal: Health technology assessment (Winchester, England) 20111201

Title: Geminin overexpression induces mammary tumors via suppressing cytokinesis.

Journal: Oncotarget 20111201

Title: Cerebral venous thrombosis in an individual with multiple myeloma treated with lenalidomide.

Journal: Journal of the American Geriatrics Society 20111201

Title: [Reported use of thalidomide in multiple myeloma: presentation of problems in the Thaled® outpatient department].

Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20111201

Title: Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes.

Journal: Clinics (Sao Paulo, Brazil) 20111201

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology 20111201

Title: Is the low-thalidomide dose MPT regimen beneficial?

Journal: The Korean journal of internal medicine 20111201

Title: A combination of melphalan, prednisone, and 50 mg thalidomide treatment in non-transplant-candidate patients with newly diagnosed multiple myeloma.

Journal: The Korean journal of internal medicine 20111201

Title: Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of concept.

Journal: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20111201

Title: Tumor Necrosis Factor-alpha and Apoptosis Following Spinal Nerve Ligation Injury in Rats.

Journal: The Korean journal of pain 20111201

Title: Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy.

Journal: CNS & neurological disorders drug targets 20111201

Title: Thalidomide: an old drug with new action.

Journal: Journal of chemotherapy (Florence, Italy) 20111201

Title: [Thrombotic complications following the treatment of multiple myeloma with new agents].

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20111201

Title: Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

Journal: The Korean journal of hematology 20111201

Title: Disruption of embryonic vascular development in predictive toxicology.

Journal: Birth defects research. Part C, Embryo today : reviews 20111201

Title: [Thalidomide Celgene: a practical guideline for community pharmacists].

Journal: Journal de pharmacie de Belgique 20111201

Title: Timing of the high-dose therapy in the area of new drugs.

Journal: Srpski arhiv za celokupno lekarstvo 20111201

Title: [New concept of the treatment in elderly patients with multiple myeloma].

Journal: Srpski arhiv za celokupno lekarstvo 20111201

Title: Abstracts of the 6th cachexia conference, milan, Italy, december 8-10, 2011.

Journal: Journal of cachexia, sarcopenia and muscle 20111201

Title: Diagnostic and prognostic markers in differentiated thyroid cancer.

Journal: Current genomics 20111201

Title: Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Journal: Blood 20111124

Title: Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.

Journal: Blood 20111124

Title: Thalidomide modulates Mycobacterium leprae-induced NF-κB pathway and lower cytokine response.

Journal: European journal of pharmacology 20111116

Title: Amyloidosis.

Journal: BMJ (Clinical research ed.) 20111116

Title: Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.

Journal: Cancer 20111115

Title: A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.

Journal: Blood 20111110

Title: US lawsuit extends thalidomide's reach.

Journal: Nature 20111110

Title: Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide.

Journal: Blood 20111103

Title: [Myelodysplastic syndrome. What can be achieved with supportive therapy and new approaches].

Journal: MMW Fortschritte der Medizin 20111103

Title: Thyroid dysfunction from antineoplastic agents.

Journal: Journal of the National Cancer Institute 20111102

Title: Metastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin.

Journal: Current pharmaceutical biotechnology 20111101

Title: [Current treatment of AL amyloidosis].

Journal: Nephrologie & therapeutique 20111101

Title: Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.

Journal: British journal of pharmacology 20111101

Title: [New insights in the treatment of myeloma with renal failure].

Journal: Nephrologie & therapeutique 20111101

Title: Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion--the GFM experience.

Journal: Leukemia research 20111101

Title: Reducing neurotoxicity in the management of multiple myeloma.

Journal: Leukemia & lymphoma 20111101

Title: Lenalidomide in del 5q MDS: responses and side effects revisited.

Journal: Leukemia research 20111101

Title: Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation.

Journal: Gastroenterology 20111101

Title: Environmental impact on vascular development predicted by high-throughput screening.

Journal: Environmental health perspectives 20111101

Title: Anti-myelin associated glycoprotein neuropathy responding to lenalidomide.

Journal: Leukemia research 20111101

Title: Dihydroxypentamethoxyflavone down-regulates constitutive and inducible signal transducers and activators of transcription-3 through the induction of tyrosine phosphatase SHP-1.

Journal: Molecular pharmacology 20111101

Title: Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.

Journal: Biochemical pharmacology 20111101

Title: Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.

Journal: International journal of oncology 20111101

Title: Cytogenetic and molecular abnormalities in myelodysplastic syndrome.

Journal: Current molecular medicine 20111101

Title: Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.

Journal: British journal of haematology 20111101

Title: Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies.

Journal: Current cancer drug targets 20111101

Title: Bortezomib for previously untreated multiple myeloma.

Journal: Expert opinion on pharmacotherapy 20111101

Title: Knowledge transfer and translation: examining how teratogen information is disseminated.

Journal: Birth defects research. Part A, Clinical and molecular teratology 20111101

Title: Stable and orally bio-available pro-drugs of CPS11.

Journal: Bioorganic & medicinal chemistry letters 20111101

Title: Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?

Journal: American journal of hematology 20111101

Title: Clinical experience with antiangiogenic therapy in leukemia.

Journal: Current cancer drug targets 20111101

Title: Antiangiogenesis in myelodysplastic syndrome.

Journal: Current cancer drug targets 20111101

Title: Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

Journal: British journal of haematology 20111101

Title: Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20111101

Title: [Chemotherapy-induced peripheral neuropathy].

Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20111101

Title: Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.

Journal: Expert reviews in molecular medicine 20111101

Title: Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide.

Journal: Anticancer research 20111101

Title: Bleeding and thrombosis in multiple myeloma and related plasma cell disorders.

Journal: Seminars in thrombosis and hemostasis 20111101

Title: [Treatment for Crow-Fukase (POEMS) syndrome].

Journal: Rinsho shinkeigaku = Clinical neurology 20111101

Title: AL amyloidosis in a patient with macroglossia.

Journal: ANZ journal of surgery 20111101

Title: Secondary gliosarcoma after the treatment of primary glioblastoma multiforme.

Journal: North American journal of medical sciences 20111101

Title: [Pregnancy and inflammatory bowel disease: experience in 17 patients].

Journal: Revista medica de Chile 20111101

Title: [The Neurosedyn disaster became a starting shot. The drug approval process was changed and new era of patient safety was initiated].

Journal: Lakartidningen 20111101

Title: Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

Journal: Blood 20111027

Title: Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.

Journal: Blood 20111027

Title: Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.

Journal: Blood 20111020

Title: Erythrodermic lichen planus.

Journal: Dermatology online journal 20111015

Title: A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.

Journal: Blood 20111006

Title: Mantle cell lymphoma: the promise of new treatment options.

Journal: Critical reviews in oncology/hematology 20111001

Title: [Toxic epidermal necrolysis treated with cyclosporin A].

Journal: Medicina intensiva 20111001

Title: Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20111001

Title: Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma.

Journal: Cancer chemotherapy and pharmacology 20111001

Title: Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib.

Journal: Annals of hematology 20111001

Title: Initial testing of lenalidomide by the pediatric preclinical testing program.

Journal: Pediatric blood & cancer 20111001

Title: Role of TNF-alpha during central sensitization in preclinical studies.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20111001

Title: Calciphylaxis, occurring 10 weeks after hypercalcaemia, in a patient with multiple myeloma.

Journal: British journal of haematology 20111001

Title: Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy.

Journal: Leukemia 20111001

Title: A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant.

Journal: Leukemia & lymphoma 20111001

Title: Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p.

Journal: European journal of haematology 20111001

Title: Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.

Journal: Annals of hematology 20111001

Title: Protective effect of thalidomide against N-methyl-D-aspartate-induced retinal neurotoxicity.

Journal: Journal of neuroscience research 20111001

Title: Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.

Journal: Rheumatology (Oxford, England) 20111001

Title: Racemates revisited: heterochiral assemblies and the example of DL-thalidomide.

Journal: Xenobiotica; the fate of foreign compounds in biological systems 20111001

Title: Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma.

Journal: Leukemia 20111001

Title: Overview: developmental toxicology: new directions.

Journal: Birth defects research. Part B, Developmental and reproductive toxicology 20111001

Title: Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma.

Journal: American journal of hematology 20111001

Title: Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia.

Journal: American journal of hematology 20111001

Title: Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias.

Journal: American journal of hematology 20111001

Title: Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20111001

Title: Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide.

Journal: Clinical lymphoma, myeloma & leukemia 20111001

Title: Novel therapies in MM: from the aspect of preclinical studies.

Journal: International journal of hematology 20111001

Title: Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20111001

Title: Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.

Journal: Japanese journal of clinical oncology 20111001

Title: Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001

Title: Spotlight on lenalidomide in relapsed or refractory multiple myeloma.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20111001

Title: Role of lenalidomide in the treatment of myelodysplastic syndromes.

Journal: Seminars in oncology 20111001

Title: Treatment of higher-risk myelodysplastic syndrome.

Journal: Seminars in oncology 20111001

Title: Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20111001

Title: The role of HIF-1, angiopoietin-2, Dll4 and Notch1 in bleeding gastrointestinal vascular malformations and thalidomide-associated actions: a pilot in vivo study.

Journal: Journal of digestive diseases 20111001

Title: The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy.

Journal: Genes, chromosomes & cancer 20111001

Title: [Treatment of multiple myeloma by immunomodulatory drugs].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20111001

Title: [Novel therapeutics for myelodysplastic syndromes].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20111001

Title: Evolving paradigms in the treatment of newly diagnosed multiple myeloma.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20111001

Title: Management of relapsed and relapsed/refractory multiple myeloma.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20111001

Title: Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.

Journal: Cancer control : journal of the Moffitt Cancer Center 20111001

Title: Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.

Journal: Journal of Korean medical science 20111001

Title: [Treatment of myeloma when high dose therapy is not possible. New drugs--alternatives for elderly patients].

Journal: Lakartidningen 20111001

Title: How I treat splenomegaly in myelofibrosis.

Journal: Blood cancer journal 20111001

Title: Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3.

Journal: Blood 20110929

Title: Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia.

Journal: Blood 20110929

Title: Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease.

Journal: Blood 20110915

Title: A third-generation IMiD for MM.

Journal: Blood 20110915

Title: Successful treatment with bortezomib and thalidomide for POEMS syndrome.

Journal: Annals of hematology 20110901

Title: Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients.

Journal: Annals of hematology 20110901

Title: Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide.

Journal: The British journal of radiology 20110901

Title: Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide.

Journal: Leukemia research 20110901

Title: Poor tolerability of thalidomide in end-stage oesophageal cancer.

Journal: European journal of cancer care 20110901

Title: Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma.

Journal: European journal of haematology 20110901

Title: Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion.

Journal: Leukemia research 20110901

Title: Activation of coagulation by a thalidomide-based regimen.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110901

Title: Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.

Journal: Blood 20110901

Title: Thalidomide induces apoptosis in human oral squamous cell carcinoma cell line with altered expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Journal: Oral oncology 20110901

Title: Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice.

Journal: Journal of neurochemistry 20110901

Title: Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation.

Journal: Leukemia research 20110901

Title: Are you 'tilting at windmills' or undertaking a valid clinical trial?

Journal: Yonsei medical journal 20110901

Title: Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110901

Title: What can we learn from the thalidomide experience: an ophthalmologic perspective.

Journal: Current opinion in ophthalmology 20110901

Title: Lenalidomide-induced purpuric eruption: a new adverse cutaneous reaction.

Journal: Journal of the American Academy of Dermatology 20110901

Title: Parvovirus B19-induced type II mixed cryoglobulinemia.

Journal: The American journal of medicine 20110901

Title: Pulmonary alveolar hemorrhage possibly associated with lenalidomide use.

Journal: International journal of hematology 20110901

Title: Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia.

Journal: Cancer 20110901

Title: Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis.

Journal: Expert review of anti-infective therapy 20110901

Title: A computational approach to finding novel targets for existing drugs.

Journal: PLoS computational biology 20110901

Title: Immunomodulatory properties of thalidomide analogs: pomalidomide and lenalidomide, experimental and therapeutic applications.

Journal: Recent patents on endocrine, metabolic & immune drug discovery 20110901

Title: Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.

Journal: Pharmacotherapy 20110901

Title: A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.

Journal: PLoS computational biology 20110901

Title: [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].

Journal: Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20110901

Title: Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats.

Journal: Indian journal of experimental biology 20110901

Title: Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.

Journal: PLoS pathogens 20110901

Title: NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma.

Journal: The Lancet. Oncology 20110901

Title: Successful Chemotherapy Following Autologous Stem Cell Transplantation in Multiple Myeloma and Multi-organ Dysfunction with Infiltration of Eosinophils: A Case Report.

Journal: Cancer research and treatment : official journal of Korean Cancer Association 20110901

Title: Treatment of chronic graft-versus-host disease: Past, present and future.

Journal: The Korean journal of hematology 20110901

Title: Clinical significance of anti-mitochondrial antibodies in a patient with chronic graft-versus-host disease following hematopoietic stem cell transplantation.

Journal: The Korean journal of hematology 20110901

Title: Longterm clinical remission of oral and cutaneous pemphigus with thalidomide.

Journal: International journal of dermatology 20110901

Title: Intra-atrial tumor thrombi secondary to hepatocellular carcinoma responding to chemotherapy.

Journal: North American journal of medical sciences 20110901

Title: Cardiac amyloidosis: a treatable disease, often overlooked.

Journal: Circulation 20110830

Title: Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis.

Journal: Blood 20110825

Title: Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms.

Journal: Journal of medicinal chemistry 20110825

Title: Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.

Journal: British journal of cancer 20110823

Title: Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma.

Journal: Blood 20110818

Title: In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110815

Title: The role of teratology information services in screening for teratogenic exposures: challenges and opportunities.

Journal: American journal of medical genetics. Part C, Seminars in medical genetics 20110815

Title: Chemical 'Jekyll and Hyde's: small-molecule inhibitors of developmental signaling pathways.

Journal: Chemical Society reviews 20110814

Title: [The cutting-edge of medicine; Crow-Fukase (POEMS) syndrome: diagnosis, pathophysiology, and treatments].

Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20110810

Title: Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.

Journal: Blood 20110804

Title: Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

Journal: Blood 20110804

Title: ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.

Journal: Annals of hematology 20110801

Title: In vivo efficacy of griseofulvin against multiple myeloma.

Journal: Leukemia research 20110801

Title: Intraplaque haemorrhages as the trigger of plaque vulnerability.

Journal: European heart journal 20110801

Title: [Papular drug eruption along the lines of Blaschko caused by lenalidomide].

Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20110801

Title: Treatment of cutaneous lupus.

Journal: Current rheumatology reports 20110801

Title: Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified.

Journal: Leukemia & lymphoma 20110801

Title: Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: induction of IL-10 expression in the stromal layers.

Journal: Leukemia research 20110801

Title: Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.

Journal: British journal of haematology 20110801

Title: On the use of antiangiogenetic medications for retinopathy of prematurity.

Journal: Acta paediatrica (Oslo, Norway : 1992) 20110801

Title: Strong anticonvulsant effect of thalidomide on amygdaloid kindling.

Journal: Epilepsy research 20110801

Title: Antiangiogenic agents and endothelin antagonists in advanced castration resistant prostate cancer.

Journal: European journal of cancer (Oxford, England : 1990) 20110801

Title: Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.

Journal: American journal of hematology 20110801

Title: Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma.

Journal: Expert opinion on investigational drugs 20110801

Title: Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response.

Journal: British journal of haematology 20110801

Title: The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin.

Journal: British journal of haematology 20110801

Title: Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.

Journal: Journal of the American Academy of Dermatology 20110801

Title: Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.

Journal: The Lancet. Oncology 20110801

Title: [New concepts in human oncology: is it possible to use them in veterinary medicine as well?].

Journal: Schweizer Archiv fur Tierheilkunde 20110801

Title: Lenalidomide in combination with dexamethasone induced rhabdomyolysis in a multiple myeloma patient treated with pravastatin.

Journal: International journal of hematology 20110801

Title: Acute lung toxicity related to pomalidomide.

Journal: Chest 20110801

Title: Identification and evaluation of a panel of serum biomarkers for predicting response to thalidomide in multiple myeloma patients.

Journal: Expert review of proteomics 20110801

Title: [IMiDs in hematology].

Journal: Bulletin du cancer 20110801

Title: Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia.

Journal: Aging 20110801

Title: [Efficacy of thalidomide for treatment of juvenile idiopathic arthritis].

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20110801

Title: TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms.

Journal: Cell death & disease 20110801

Title: [Current treatment strategies with novel agents for multiple myeloma].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20110801

Title: [Development of novel agents for multiple myeloma; now and the future].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20110801

Title: [Present status and perspective of targeted therapy for B-cell lymphoma].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20110801

Title: [Thalidomide-induced sensory neuropaty in patients with multiple myeloma].

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20110801

Title: Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.

Journal: Clinical epigenetics 20110801

Title: Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice.

Journal: Blood 20110728

Title: Comparison of thalidomide and lenalidomide as therapy for myelofibrosis.

Journal: Blood 20110728

Title: A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605.

Journal: Blood 20110721

Title: Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial.

Journal: Blood 20110721

Title: Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20110715

Title: Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

Journal: Journal of medicinal chemistry 20110714

Title: Response to radiation in renal medullary carcinoma.

Journal: Rare tumors 20110711

Title: Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110710

Title: Significantly reduced regulatory T cell population in patients with untreated multiple myeloma.

Journal: Leukemia research 20110701

Title: An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110701

Title: Primary plasma cell leukemia: a retrospective multicenter study of 73 patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110701

Title: Fatal ischemic stroke in a patient receiving lenalidomide for multiple myeloma.

Journal: Clinical neurology and neurosurgery 20110701

Title: Anti-inflammatory effect of α,β-amyrin, a triterpene from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20110701

Title: Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701

Title: Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma.

Journal: Leukemia 20110701

Title: Similarities and differences between spondyloarthritis in Asia and other parts of the world.

Journal: Current opinion in rheumatology 20110701

Title: Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?

Journal: Blood reviews 20110701

Title: Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.

Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110701

Title: Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20110701

Title: Fluorothalidomide: a characterization of maternal and developmental toxicity in rabbits and mice.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20110701

Title: Thalidomide: the tragedy of birth defects and the effective treatment of disease.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20110701

Title: Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant.

Journal: Leukemia & lymphoma 20110701

Title: A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients.

Journal: British journal of haematology 20110701

Title: Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.

Journal: Bioorganic & medicinal chemistry 20110701

Title: Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.

Journal: American journal of hematology 20110701

Title: POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.

Journal: American journal of hematology 20110701

Title: Cost effectiveness of treatments for relapsed/refractory multiple myeloma: response to a methodology. RE: Hornberger J, Rickert J, Dhawan R, Liwing J, Aschan J, Löthgren M. The cost effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective. European Journal of Haematology 2010; 85 (6):484-491.

Journal: European journal of haematology 20110701

Title: Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Journal: The American journal of pathology 20110701

Title: Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.

Journal: Haematologica 20110701

Title: Pathologic mandibular fracture as the presenting manifestation of multiple myeloma.

Journal: The Journal of craniofacial surgery 20110701

Title: [Molecular mechanisms of lenalidomide for the treatment of myelodysplastic syndromes].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20110701

Title: [Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: report of one case].

Journal: Revista medica de Chile 20110701

Title: Epidemiology, diagnosis, and management of von Willebrand disease in India.

Journal: Seminars in thrombosis and hemostasis 20110701

Title: Memantine abolishes the formation of cocaine-induced conditioned place preference possibly via its IL-6-modulating effect in medial prefrontal cortex.

Journal: Behavioural brain research 20110620

Title: International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

Journal: Blood 20110609

Title: Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer.

Journal: British journal of cancer 20110607

Title: Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells.

Journal: Journal of cellular and molecular medicine 20110601

Title: The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP.

Journal: Annals of hematology 20110601

Title: Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide.

Journal: Leukemia research 20110601

Title: Advances in MRI assessment of gliomas and response to anti-VEGF therapy.

Journal: Current neurology and neuroscience reports 20110601

Title: What has happened to people affected by thalidomide 50 years on?

Journal: Irish journal of medical science 20110601

Title: New immunomodulatory drugs in myeloma.

Journal: Current hematologic malignancy reports 20110601

Title: Signal transducer and activator of transcription 3 pathway mediates genipin-induced apoptosis in U266 multiple myeloma cells.

Journal: Journal of cellular biochemistry 20110601

Title: Treatment of newly diagnosed myeloma in patients not eligible for transplantation.

Journal: Current hematologic malignancy reports 20110601

Title: Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma.

Journal: Leukemia 20110601

Title: Treatment of newly diagnosed multiple myeloma in transplant-eligible patients.

Journal: Current hematologic malignancy reports 20110601

Title: Quick detection of overexpressed genes caused by myeloma-specific chromosomal translocations using multiplex RT-PCR.

Journal: International journal of molecular medicine 20110601

Title: Behçet's Disease.

Journal: Current treatment options in neurology 20110601

Title: Pomalidomide suppresses cerulein-induced acute pancreatitis in mice.

Journal: Journal of gastroenterology 20110601

Title: Management of lower-risk myelodysplastic syndromes: the art and evidence.

Journal: Current hematologic malignancy reports 20110601

Title: Effective use of thalidomide in the treatment of recurrent metastatic chordoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110601

Title: Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: results of a retrospective case review.

Journal: American journal of hematology 20110601

Title: Diffuse alveolar hemorrhage associated with lenalidomide.

Journal: International journal of hematology 20110601

Title: Adverse drug reactions in utero: perspectives on teratogens and strategies for the future.

Journal: Clinical pharmacology and therapeutics 20110601

Title: A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature.

Journal: The American journal of tropical medicine and hygiene 20110601

Title: Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report.

Journal: Journal of Korean medical science 20110601

Title: New agents in follicular lymphoma.

Journal: Best practice & research. Clinical haematology 20110601

Title: Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.

Journal: Clinical lymphoma, myeloma & leukemia 20110601

Title: Thalidomide attenuates graft arteriosclerosis of aortic transplant in a rat model.

Journal: Transplantation proceedings 20110601

Title: The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma.

Journal: The Korean journal of hematology 20110601

Title: Variant Burkitt-type translocation (8;22)(q24;q11) in plasma cell myeloma.

Journal: The Korean journal of hematology 20110601

Title: The past, present and future of clinical research.

Journal: Clinics (Sao Paulo, Brazil) 20110601

Title: Assessing the benefit: risk ratio of a drug--randomized and naturalistic evidence.

Journal: Dialogues in clinical neuroscience 20110601

Title: High-risk multiple myeloma: does it still exist?

Journal: Clinical lymphoma, myeloma & leukemia 20110601

Title: Management of myeloma: an Italian perspective.

Journal: Clinical lymphoma, myeloma & leukemia 20110601

Title: Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110515

Title: Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related α-glucosidase inhibitors and liver X receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters 20110515

Title: Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity.

Journal: Bioorganic & medicinal chemistry 20110515

Title: Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response.

Journal: Cancer 20110515

Title: Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone.

Journal: Cancer 20110515

Title: Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin-proteasome system.

Journal: The Journal of biological chemistry 20110513

Title: IMiD immunomodulatory compounds block C/EBP{beta} translation through eIF4E down-regulation resulting in inhibition of MM.

Journal: Blood 20110512

Title: Unexpected erythroid and cytogenetic responses after discontinuation of a short course of lenalidomide as a result of severe skin rash in a patient with 5q syndrome.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510

Title: Future directions of next-generation novel therapies, combination approaches, and the development of personalized medicine in myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510

Title: Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510

Title: Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia.

Journal: Annals of hematology 20110501

Title: A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).

Journal: Annals of the rheumatic diseases 20110501

Title: Teratogenic effects of thalidomide: molecular mechanisms.

Journal: Cellular and molecular life sciences : CMLS 20110501

Title: Novel therapeutic approaches for pulmonary fibrosis.

Journal: British journal of pharmacology 20110501

Title: Efficacy of thalidomide in the treatment of prurigo nodularis.

Journal: Acta dermato-venereologica 20110501

Title: Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.

Journal: Leukemia research 20110501

Title: Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US.

Journal: Radiology 20110501

Title: Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement.

Journal: Leukemia 20110501

Title: Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.

Journal: Leukemia & lymphoma 20110501

Title: A novel embryological theory of autism causation involving endogenous biochemicals capable of initiating cellular gene transcription: a possible link between twelve autism risk factors and the autism 'epidemic'.

Journal: Medical hypotheses 20110501

Title: Pomalidomide therapy for myeloma.

Journal: Expert opinion on investigational drugs 20110501

Title: Durable hematological response and improvement of nephrotic syndrome on thalidomide therapy in a patient with refractory light chain deposition disease.

Journal: International journal of hematology 20110501

Title: [Study to castrate-resistant prostate cancer: AUO study AP 60/10].

Journal: Der Urologe. Ausg. A 20110501

Title: Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management.

Journal: American journal of hematology 20110501

Title: Role of maintenance therapy after autologous stem cell transplant for multiple myeloma: lessons for cancer therapy.

Journal: Mayo Clinic proceedings 20110501

Title: Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.

Journal: Blood 20110428

Title: Thalidomide prevents the progression of peritoneal fibrosis in mice.

Journal: Acta histochemica et cytochemica 20110428

Title: Early toxicity predicts long-term survival in high-grade glioma.

Journal: British journal of cancer 20110426

Title: Synthesized pyridine compound derivatives decreased TNF alpha and adhesion molecules and ameliorated HSV-induced inflammation in a mouse model.

Journal: European journal of pharmacology 20110425

Title: The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia.

Journal: Blood 20110421

Title: Current evidence of the management of undifferentiated spondyloarthritis: a systematic literature review.

Journal: Seminars in arthritis and rheumatism 20110401

Title: Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment.

Journal: Annals of hematology 20110401

Title: Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center.

Journal: Endocrine 20110401

Title: Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.

Journal: The Journal of biological chemistry 20110401

Title: Fetal exposure to teratogens: evidence of genes involved in autism.

Journal: Neuroscience and biobehavioral reviews 20110401

Title: Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401

Title: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis.

Journal: Leukemia 20110401

Title: A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.

Journal: Leukemia 20110401

Title: mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain.

Journal: Neuroscience research 20110401

Title: Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis.

Journal: Journal of thrombosis and haemostasis : JTH 20110401

Title: Peripheral nerve injury leads to working memory deficits and dysfunction of the hippocampus by upregulation of TNF-α in rodents.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110401

Title: Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110401

Title: Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110401

Title: Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients.

Journal: European journal of cancer (Oxford, England : 1990) 20110401

Title: Pomalidomide therapy for multiple myeloma and myelofibrosis: an update.

Journal: Leukemia & lymphoma 20110401

Title: Recent advances in myeloma treatment.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20110401

Title: A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patients.

Journal: Proteomics 20110401

Title: Evaluation of the reproductive and developmental risks of caffeine.

Journal: Birth defects research. Part B, Developmental and reproductive toxicology 20110401

Title: The role of bortezomib, thalidomide and lenalidomide in the management of multiple myeloma: an overview of clinical and economic information.

Journal: PharmacoEconomics 20110401

Title: Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.

Journal: Cancer 20110401

Title: Multiple myeloma treatment strategies with novel agents in 2011: a European perspective.

Journal: The oncologist 20110401

Title: Type 1 cryoglobulinemia: response to thalidomide and lenalidomide.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20110401

Title: Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.

Journal: American journal of hematology 20110401

Title: Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.

Journal: Seminars in thrombosis and hemostasis 20110401

Title: Gender-specific asthma treatment.

Journal: Allergy, asthma & immunology research 20110401

Title: Diet, nutrition and modulation of genomic expression in fetal origins of adult disease.

Journal: Journal of nutrigenetics and nutrigenomics 20110401

Title: Drug safety in pregnancy--monitoring congenital anomalies.

Journal: Journal of nursing management 20110401

Title: A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment.

Journal: PLoS neglected tropical diseases 20110401

Title: The enhancement of radiosensitivity in human esophageal carcinoma cells by thalidomide and its potential mechanism.

Journal: Cancer biotherapy & radiopharmaceuticals 20110401

Title: [Effect of different regimens on bone disease of multiple myeloma].

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110401

Title: Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.

Journal: Clinical lymphoma, myeloma & leukemia 20110401

Title: [The efficacy and safety of bortezomib plus thalidomide in treatment of newly diagnosed multiple myeloma].

Journal: Zhonghua nei ke za zhi 20110401

Title: Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review.

Journal: Journal of clinical medicine research 20110401

Title: Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.

Journal: Clinical advances in hematology & oncology : H&O 20110401

Title: Subcutaneous sarcoidosis: a rare involvement of the paralateral nasal region.

Journal: Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20110401

Title: A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels.

Journal: British journal of cancer 20110329

Title: Lenalidomide in treating AIDS-related Kaposi's sarcoma.

Journal: AIDS (London, England) 20110327

Title: Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.

Journal: Drugs 20110326

Title: In vivo formation of a glutathione conjugate derived from thalidomide in humanized uPA-NOG mice.

Journal: Chemical research in toxicology 20110321

Title: Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110320

Title: The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.

Journal: International journal of cancer 20110315

Title: Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110315

Title: Treatment options for relapsed and refractory multiple myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110315

Title: Advances in the biology and treatment of bone disease in multiple myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110315

Title: Treatment of pediatric refractory Crohn's disease with thalidomide.

Journal: World journal of gastroenterology 20110314

Title: Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

Title: Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data.

Journal: International urology and nephrology 20110301

Title: Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide.

Journal: Bone marrow transplantation 20110301

Title: In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents.

Journal: Cancer chemotherapy and pharmacology 20110301

Title: High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma.

Journal: Bone marrow transplantation 20110301

Title: Kidney dysfunction during lenalidomide treatment for AL amyloidosis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110301

Title: Les bébés du thalidomide.

Journal: Presse medicale (Paris, France : 1983) 20110301

Title: Maternal exposure to ambient levels of benzene and neural tube defects among offspring: Texas, 1999-2004.

Journal: Environmental health perspectives 20110301

Title: International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocols.

Journal: Cancer 20110301

Title: Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo.

Journal: Leukemia research 20110301

Title: Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services.

Journal: Congenital anomalies 20110301

Title: Causes of birth defects: lessons from history.

Journal: Congenital anomalies 20110301

Title: Immunomodulatory drugs increase endothelial tissue factor expression in vitro.

Journal: Thrombosis research 20110301

Title: Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells.

Journal: European journal of pharmacology 20110301

Title: Chemotherapy-induced neuropathic pain.

Journal: Current opinion in supportive and palliative care 20110301

Title: Bortezomib and thalidomide, a steroid free regimen in newly diagnosed patients with multiple myeloma.

Journal: British journal of haematology 20110301

Title: Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110301

Title: Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110301

Title: Management of older patients with multiple myeloma.

Journal: Blood reviews 20110301

Title: Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study.

Journal: The Lancet. Oncology 20110301

Title: Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients.

Journal: International journal of hematology 20110301

Title: In vitro thalidomide does not interfere with the activation of complement by M. leprae.

Journal: Journal of drugs in dermatology : JDD 20110301

Title: Novel agents for the treatment of acute myeloid leukemia in the older patient.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20110301

Title: Recent advances in anti-angiogenic therapy of cancer.

Journal: Oncotarget 20110301

Title: Neuropathic pain and psychological morbidity in patients with treated leprosy: a cross-sectional prevalence study in Mumbai.

Journal: PLoS neglected tropical diseases 20110301

Title: Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.

Journal: PLoS neglected tropical diseases 20110301

Title: Myelodysplastic syndrome presenting as generalized granulomatous dermatitis.

Journal: Archives of dermatology 20110301

Title: Lenalidomide - current understanding of mechanistic properties.

Journal: Anti-cancer agents in medicinal chemistry 20110301

Title: Dermatological complications following initiation of lenalidomide in a patient with chronic lymphocytic leukaemia.

Journal: Internal medicine journal 20110301

Title: Treatment of myelodysplastic syndromes in elderly patients.

Journal: Advances in therapy 20110301

Title: Management of the adverse effects of lenalidomide in multiple myeloma.

Journal: Advances in therapy 20110301

Title: Lenalidomide treatment for patients with multiple myeloma: diagnosis and management of most frequent adverse events.

Journal: Advances in therapy 20110301

Title: A review of the history, properties, and use of the immunomodulatory compound lenalidomide.

Journal: Annals of the New York Academy of Sciences 20110301

Title: Current treatment strategies for castration-resistant prostate cancer.

Journal: Korean journal of urology 20110301

Title: [Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20110301

Title: Lenalidomide in CLL: what is the optimal dose?

Journal: Clinical advances in hematology & oncology : H&O 20110301

Title: An unusual presentation of sclerosing mesenteritis mimicking inflammatory bowel disease in a teenager.

Journal: JRSM short reports 20110301

Title: A study on habit of preservation of prescriptions by pregnant women in India.

Journal: Nepal Medical College journal : NMCJ 20110301

Title: Foundation and progress of Japanese society of toxicologic pathology*.

Journal: Journal of toxicologic pathology 20110301

Title: MEK and MAF in myeloma therapy.

Journal: Blood 20110224

Title: Experimental therapeutics for patients with myeloproliferative neoplasias.

Journal: Cancer 20110215

Title: Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.

Journal: British journal of cancer 20110215

Title: Development and characterization of parenteral nanoemulsions containing thalidomide.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20110214

Title: A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.

Journal: Blood 20110210

Title: Total therapy 2 in treatment of multiple myeloma: questions about gene expression profiling and treatment-related mortality.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110210

Title: Hypomethylating agents and other novel strategies in myelodysplastic syndromes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110210

Title: Asymmetric synthesis of both mirror images of 3'-fluorothalidomide by enantiodivergent fluorination using a single, cinchona alkaloid.

Journal: Organic letters 20110204

Title: The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.

Journal: Blood 20110203

Title: Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.

Journal: Investigational new drugs 20110201

Title: Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110201

Title: Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.

Journal: Annals of hematology 20110201

Title: Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma.

Journal: Leukemia research 20110201

Title: Thalidomide treatment attenuates chemotherapy-induced gonadal toxicity.

Journal: Fertility and sterility 20110201

Title: Anti-tumour effects of transcatheter arterial embolisation administered in combination with thalidomide in a rabbit VX2 liver tumour model.

Journal: The British journal of radiology 20110201

Title: A phase-2 trial of low-dose pomalidomide in myelofibrosis.

Journal: Leukemia 20110201

Title: Langerhans cell histiocytosis: old disease new treatment.

Journal: QJM : monthly journal of the Association of Physicians 20110201

Title: Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.

Journal: Current allergy and asthma reports 20110201

Title: Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide.

Journal: Haematologica 20110201

Title: Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.

Journal: Haematologica 20110201

Title: Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide.

Journal: Clinical immunology (Orlando, Fla.) 20110201

Title: Review article: the role of non-biological drugs in refractory inflammatory bowel disease.

Journal: Alimentary pharmacology & therapeutics 20110201

Title: Clinical impact of chromosomal aberrations in multiple myeloma.

Journal: Journal of internal medicine 20110201

Title: Anti-TNF therapy in the injured spinal cord.

Journal: Trends in pharmacological sciences 20110201

Title: Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study.

Journal: Journal of clinical pharmacy and therapeutics 20110201

Title: FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature.

Journal: International journal of hematology 20110201

Title: Lenalidomide in the treatment of chronic lymphocytic leukemia.

Journal: Expert opinion on investigational drugs 20110201

Title: Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20110201

Title: Angiogenesis and invasion in glioma.

Journal: Brain tumor pathology 20110201

Title: Present state and future perspectives of using pluripotent stem cells in toxicology research.

Journal: Archives of toxicology 20110201

Title: Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.

Journal: Clinical lymphoma, myeloma & leukemia 20110201

Title: Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma.

Journal: International journal of hematology 20110201

Title: Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.

Journal: Haematologica 20110201

Title: [Biodistribution of nanosilica particles in pregnant mice and the potential risk on the reproductive development].

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110201

Title: [Crow-Fukase syndrome (POEMS syndrome)].

Journal: Brain and nerve = Shinkei kenkyu no shinpo 20110201

Title: Development of multiple myeloma in a case of longstanding ankylosing spondylitis: more than a coincidence?

Journal: International journal of rheumatic diseases 20110201

Title: Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.

Journal: Expert review of hematology 20110201

Title: Biology and treatment of the 5q- syndrome.

Journal: Expert review of hematology 20110201

Title: [Therapy strategies for transplant candidates of multiple myeloma].

Journal: Zhongguo shi yan xue ye xue za zhi 20110201

Title: [Molecular mechanism of thalidomide teratogenicity].

Journal: Seikagaku. The Journal of Japanese Biochemical Society 20110201

Title: [Clinical observation on compound danshen for thalidomide-related venous thromboembolism prophylaxis].

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110201

Title: The courage of one's convictions: the due diligence of Frances Oldham Kelsey at the FDA.

Journal: Molecular interventions 20110201

Title: Environmental implications of nanotechnology--an update.

Journal: International journal of environmental research and public health 20110201

Title: Pemphigus autoimmunity: hypotheses and realities.

Journal: Autoimmunity 20110201

Title: Talactoferrin immunotherapy in metastatic renal cell carcinoma: a case series of four long-term survivors.

Journal: Journal of clinical medicine research 20110201

Title: Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110120

Title: Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110120

Title: PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells.

Journal: British journal of cancer 20110118

Title: Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma.

Journal: Blood 20110113

Title: Clinically relevant drug interactions between anticancer drugs and psychotropic agents.

Journal: European journal of cancer care 20110101

Title: Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen.

Journal: Bone marrow transplantation 20110101

Title: Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience.

Journal: Annals of hematology 20110101

Title: Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study.

Journal: Leukemia research 20110101

Title: Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110101

Title: Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110101

Title: Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas.

Journal: Acta paediatrica (Oslo, Norway : 1992) 20110101

Title: Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers.

Journal: Cancer immunology, immunotherapy : CII 20110101

Title: Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.

Journal: Cardiovascular & hematological agents in medicinal chemistry 20110101

Title: Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.

Journal: European journal of haematology 20110101

Title: Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.

Journal: Leukemia 20110101

Title: Growth Inhibition and Induction of Apoptosis in SHG-44 Glioma Cells by Chinese Medicine Formula 'Pingliu Keli'.

Journal: Evidence-based complementary and alternative medicine : eCAM 20110101

Title: Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G).

Journal: American journal of hematology 20110101

Title: Apoptosis induction by thalidomide: critical for limb teratogenicity but therapeutic potential in idiopathic pulmonary fibrosis?

Journal: Current molecular pharmacology 20110101

Title: The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.

Journal: Advances in hematology 20110101

Title: Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?

Journal: Digestive diseases and sciences 20110101

Title: Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110101

Title: A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer.

Journal: European journal of cancer (Oxford, England : 1990) 20110101

Title: Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.

Journal: Thrombosis and haemostasis 20110101

Title: Treatment of multiple myeloma in the elderly: realities and hopes.

Journal: Leukemia & lymphoma 20110101

Title: Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes.

Journal: American journal of hematology 20110101

Title: Thalidomide after lenalidomide: a possible treatment regimen in relapse refractory multiple myeloma patients.

Journal: British journal of haematology 20110101

Title: Multiple myeloma.

Journal: Annual review of medicine 20110101

Title: Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: a systematic review.

Journal: American journal of hematology 20110101

Title: Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective.

Journal: Expert opinion on drug safety 20110101

Title: International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens.

Journal: American journal of hematology 20110101

Title: Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).

Journal: Leukemia & lymphoma 20110101

Title: Treatment of patients with multiple myeloma: an overview of systematic reviews.

Journal: Acta haematologica 20110101

Title: Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis.

Journal: International journal of hematology 20110101

Title: Complete atrioventricular block secondary to bortezomib use in multiple myeloma.

Journal: Yonsei medical journal 20110101

Title: Novel agents to improve outcome of allogeneic transplantation for patients with multiple myeloma.

Journal: Future oncology (London, England) 20110101

Title: [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome].

Journal: Revue neurologique 20110101

Title: Systematic review of medical treatment in melanoma: current status and future prospects.

Journal: The oncologist 20110101

Title: Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.

Journal: Radiation oncology (London, England) 20110101

Title: Isolated spinal cord neurosarcoidosis diagnosed by cord biopsy and thalidomide trial.

Journal: Journal of Korean medical science 20110101

Title: Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.

Journal: Seminars in hematology 20110101

Title: Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma.

Journal: Cardiology research and practice 20110101

Title: An unexpected case of venous and pulmonary thrombo-embolism in a patient treated with thalidomide for refractory erythema nodosum leprosum: a case report.

Journal: Thrombosis journal 20110101

Title: Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.

Journal: BMC cancer 20110101

Title: Human Herpesvirus-8 Infection Associated with Kaposi Sarcoma, Multicentric Castleman's Disease, and Plasmablastic Microlymphoma in a Man with AIDS: A Case Report with Review of Pathophysiologic Processes.

Journal: Pathology research international 20110101

Title: Effects of immunomodulatory drugs on TNF-α and IL-12 production by purified epidermal langerhans cells and peritoneal macrophages.

Journal: BMC research notes 20110101

Title: Increased in vivo efficacy of lenalidomide by addition of piroctone olamine.

Journal: In vivo (Athens, Greece) 20110101

Title: Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up.

Journal: Annals of hepatology 20110101

Title: Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome.

Journal: BMC medical genetics 20110101

Title: Immunotherapy for lung cancers.

Journal: Journal of biomedicine & biotechnology 20110101

Title: Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.

Journal: Arthritis research & therapy 20110101

Title: Maintenance therapy for B-chronic lymphocytic leukemia.

Journal: Clinical advances in hematology & oncology : H&O 20110101

Title: Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy.

Journal: PloS one 20110101

Title: An integrated pipeline for the genome-wide analysis of transcription factor binding sites from ChIP-Seq.

Journal: PloS one 20110101

Title: Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.

Journal: PloS one 20110101

Title: Dramatic improvement of primary cutaneous amyloidosis with thalidomide.

Journal: European journal of dermatology : EJD 20110101

Title: Arterial and venous thrombosis in cancer patients.

Journal: Cardiology research and practice 20110101

Title: Old drugs, new uses.

Journal: Pediatric dentistry 20110101

Title: From antiangiogenesis to hypoxia: current research and future directions.

Journal: Cancer management and research 20110101

Title: Drug inhibition profile prediction for NFκB pathway in multiple myeloma.

Journal: PloS one 20110101

Title: Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.

Journal: Dermatologic therapy 20110101

Title: Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L.

Journal: Journal of neuroinflammation 20110101

Title: Perfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experience.

Journal: Journal of computer assisted tomography 20110101

Title: Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?

Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20110101

Title: Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report.

Journal: Journal of medical case reports 20110101

Title: Exploring old drugs for the treatment of hematological malignancies.

Journal: Current medicinal chemistry 20110101

Title: IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions.

Journal: Clinics (Sao Paulo, Brazil) 20110101

Title: Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.

Journal: Journal of neuroinflammation 20110101

Title: Therapeutics formulated to target cancer stem cells: Is it in our future?

Journal: Cancer cell international 20110101

Title: Adjuvant therapy for locally advanced renal cell cancer: a systematic review with meta-analysis.

Journal: BMC cancer 20110101

Title: Plerixafor for autologous CD34 cell mobilization.

Journal: Core evidence 20110101

Title: A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment.

Journal: Case reports in oncology 20110101

Title: An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development.

Journal: Journal of Cancer 20110101

Title: Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis.

Journal: BMC gastroenterology 20110101

Title: Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study.

Journal: BMC musculoskeletal disorders 20110101

Title: Thalidomide inhibits interferon-γ-mediated nitric oxide production in mouse vascular endothelial cells.

Journal: Cellular immunology 20110101

Title: Chemotherapy and radiotherapy for mesothelioma.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101

Title: Spontaneous huge hematoma in the abdominal wall after lenalidomide.

Journal: Internal medicine (Tokyo, Japan) 20110101

Title: Clinical assessment of bortezomib for multiple myeloma in comparison with thalidomide.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20110101

Title: Thyroid cancer: burden of illness and management of disease.

Journal: Journal of Cancer 20110101

Title: History of multiple myeloma.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101

Title: Firstline treatment and maintenance in newly diagnosed multiple myeloma patients.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101

Title: Therapy of relapsed and refractory multiple myeloma.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101

Title: Allogeneic transplantation in multiple myeloma.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101

Title: Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space.

Journal: Journal of hematology & oncology 20110101

Title: Multiple myeloma emerging after prolonged gefitinib treatment for non-small cell lung carcinoma.

Journal: Case reports in oncology 20110101

Title: KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.

Journal: Molecular vision 20110101

Title: Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives.

Journal: Arzneimittel-Forschung 20110101

Title: Natural killer cells in human cancer: from biological functions to clinical applications.

Journal: Journal of biomedicine & biotechnology 20110101

Title: The etiological role of blood-brain barrier dysfunction in seizure disorders.

Journal: Cardiovascular psychiatry and neurology 20110101

Title: A Case of Drug-Induced Hepatitis due to Lenalidomide.

Journal: Case reports in gastroenterology 20110101

Title: Human immunodeficiency virus-associated gastrointestinal disease: common endoscopic biopsy diagnoses.

Journal: Pathology research international 20110101

Title: Generation of a predictive melphalan resistance index by drug screen of B-cell cancer cell lines.

Journal: PloS one 20110101

Title: Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.

Journal: PloS one 20110101

Title: Evaluating treatments in health care: the instability of a one-legged stool.

Journal: BMC medical research methodology 20110101

Title: Nephrogenic systemic fibrosis: current concepts.

Journal: Indian journal of dermatology 20110101

Title: Chronic linear ulcerations of the inguino-crural and buttocks folds.

Journal: Indian journal of dermatology 20110101

Title: Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid.

Journal: In vivo (Athens, Greece) 20110101

Title: Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus.

Journal: Case reports in dermatology 20110101

Title: In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme.

Journal: Bioinformation 20110101

Title: Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.

Journal: Clinical & developmental immunology 20110101

Title: Bevacizumab for the treatment of recurrent glioblastoma.

Journal: Clinical Medicine Insights. Oncology 20110101

Title: Emerging strategies and therapies for treatment of Paget's disease of bone.

Journal: Drug design, development and therapy 20110101

Title: Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report.

Journal: Journal of medical case reports 20110101

Title: Complete transposition of the aorta and pulmonary artery in a Belgian Blue crossbreed calf: a case report.

Journal: BMC veterinary research 20110101

Title: Chemical modification of L-glutamine to alpha-amino glutarimide on autoclaving facilitates Agrobacterium infection of host and non-host plants: A new use of a known compound.

Journal: BMC chemical biology 20110101

Title: Scalable representations of diseases in biomedical ontologies.

Journal: Journal of biomedical semantics 20110101

Title: Sclerosing Mesenteritis: Diverse clinical presentations and dissimilar treatment options. A case series and review of the literature.

Journal: International archives of medicine 20110101

Title: Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.

Journal: BMC medical genomics 20110101

Title: An unusual cause for sicca syndrome.

Journal: Journal of postgraduate medicine 20110101

Title: Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma.

Journal: Core evidence 20110101

Title: Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors.

Journal: Journal of hematology & oncology 20110101

Title: Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatment.

Journal: Clinical, cosmetic and investigational dermatology 20110101

Title: A 'sense' of history and pediatric cardiology.

Journal: Annals of pediatric cardiology 20110101

Title: Disfiguring annular sarcoidosis improved by adalimumab.

Journal: Case reports in dermatology 20110101

Title: The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future.

Journal: Advances in hematology 20110101

Title: Anti-angiogenic treatment (sunitinib) for disseminated malignant haemangiopericytoma: a case study and review of the literature.

Journal: Case reports in oncology 20110101

Title: Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo.

Journal: BMC cancer 20110101

Title: Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma.

Journal: Clinical Medicine Insights. Oncology 20110101

Title: Mesenteric panniculitis presenting with acute non-occlusive colonic ischemia.

Journal: International archives of medicine 20110101

Title: Prevention of the β-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures.

Journal: Journal of neuroinflammation 20110101

Title: An association between hypoplastic myelodysplastic syndrome and T-prolymphocytic leukaemia.

Journal: Journal of laboratory physicians 20110101

Title: Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study.

Journal: BMC family practice 20110101

Title: Distinct biological effects of different nanoparticles commonly used in cosmetics and medicine coatings.

Journal: Cell & bioscience 20110101

Title: Multiple myeloma with lung plasmacytoma.

Journal: Lung India : official organ of Indian Chest Society 20110101

Title: Inhibition of restriction enzymes EcoRI, BamHI and HindIII by phenethylphenylphthalimides derived from thalidomide.

Journal: Chemical & pharmaceutical bulletin 20110101

Title: Evolving role of high dose stem cell therapy in multiple myeloma.

Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

Title: Extranodal testicular anaplastic versus plasmablastic plasma cell tumor: A rare case with diagnostic dilemma in a developing country.

Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

Title: Animal testing and medicine.

Journal: Heart views : the official journal of the Gulf Heart Association 20110101

Title: A 7-Year History of Necrobiotic Xanthogranuloma following Asymptomatic Multiple Myeloma: A Case Report.

Journal: Dermatology research and practice 20110101

Title: [High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma patients--single center experience].

Journal: Przeglad lekarski 20110101

Title: Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil.

Journal: PloS one 20110101

Title: Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma.

Journal: PloS one 20110101

Title: Cancer cachexia: mechanisms and clinical implications.

Journal: Gastroenterology research and practice 20110101

Title: Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.

Journal: PloS one 20110101

Title: Pyoderma gangrenosum: variation in clinical presentation at different ages.

Journal: Indian journal of dermatology 20110101

Title: Airway management in an infant with tessier N. 4 anomaly.

Journal: Journal of anaesthesiology, clinical pharmacology 20110101

Title: Toxicological screening.

Journal: Journal of pharmacology & pharmacotherapeutics 20110101

Title: Anti-cancer natural products isolated from chinese medicinal herbs.

Journal: Chinese medicine 20110101

Title: Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.

Journal: Drug design, development and therapy 20110101

Title: Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation.

Journal: The open biochemistry journal 20110101

Title: A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.

Journal: European journal of gynaecological oncology 20110101

Title: Development and disease: how susceptibility to an emerging pathogen changes through anuran development.

Journal: PloS one 20110101

Title: Pharmacoeconomic analysis in Saudi Arabia: an overdue agenda item for action.

Journal: Annals of Saudi medicine 20110101

Title: Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy.

Journal: Annals of Indian Academy of Neurology 20110101

Title: The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis.

Journal: PloS one 20110101

Title: Treatment of central nervous system tuberculosis infections and neurological complications of tuberculosis treatment.

Journal: Current pharmaceutical design 20110101

Title: Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer.

Journal: BMC cancer 20110101

Title: Current and emerging pharmacotherapies for the treatment of relapsed small cell lung cancer.

Journal: Clinical Medicine Insights. Oncology 20110101

Title: Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101

Title: Penile and scrotum swelling in juvenile dermatomyositis.

Journal: Acta reumatologica portuguesa 20110101

Title: Fertility, developmental toxicity and teratogenicity in albino rats treated with methanol sub-fraction of Carica papaya seeds.

Journal: Indian journal of pharmacology 20110101

Title: The Roles of Glutathione Peroxidases during Embryo Development.

Journal: Frontiers in molecular neuroscience 20110101

Title: Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.

Journal: Acta haematologica 20110101

Title: Renal and suprarenal insufficiency secondary to familial Mediterranean fever associated with amyloidosis: a case report.

Journal: Journal of medical case reports 20110101

Title: Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.

Journal: PloS one 20110101

Title: Hemangiomas - current therapeutic strategies.

Journal: The International journal of developmental biology 20110101

Title: Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.

Journal: Chinese medicine 20110101

Title: Langerhans cell histiocytosis: an uncommon presentation, successfully treated by thalidomide.

Journal: Indian journal of dermatology, venereology and leprology 20110101

Title: Primary Pulmonary Epithelioid Hemangioendothelioma: A Rare Cause of PET-Negative Pulmonary Nodules.

Journal: Case reports in medicine 20110101

Title: Fetal risks of maternal pharmacotherapy: identifying signals.

Journal: Handbook of experimental pharmacology 20110101

Title: Cost-effectiveness of novel relapsed-refractory multiple myeloma therapies in Norway: lenalidomide plus dexamethasone vs bortezomib.

Journal: Journal of medical economics 20110101

Title: The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.

Journal: PloS one 20110101

Title: Natural killer cells in healthy and diseased subjects.

Journal: Journal of biomedicine & biotechnology 20110101

Title: Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.

Journal: Clinical & developmental immunology 20110101

Title: Autoimmune liver disease - are there spectra that we do not know?

Journal: Comparative hepatology 20110101

Title: Response to dexamethasone is glucose-sensitive in multiple myeloma cell lines.

Journal: Journal of experimental & clinical cancer research : CR 20110101

Title: Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Journal: International journal of rheumatology 20110101

Title: Sudden significant total protein concentration change: not an analytical problem.

Journal: Journal of clinical laboratory analysis 20110101

Title: Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4.

Journal: BMC cancer 20110101

Title: Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice.

Journal: PloS one 20110101

Title: Continuous treatment in multiple myeloma - ready for prime time?

Journal: Onkologie 20110101

Title: Macroglossia due to Systemic Amyloidosis: Is There a Role for Radiotherapy?

Journal: Case reports in oncology 20110101

Title: Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy.

Journal: PloS one 20110101

Title: Thalidomide in 42 patients with prurigo nodularis Hyde.

Journal: Dermatology (Basel, Switzerland) 20110101

Title: Editorial policy in reporting ethical processes: A survey of 'instructions for authors' in International Indexed Dental Journals.

Journal: Contemporary clinical dentistry 20110101

Title: A solitary fibrous tumor of the pleura revealed by hiccups.

Journal: Case reports in medicine 20110101

Title: MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes.

Journal: Lipids in health and disease 20110101

Title: Skin as a marker of internal disease: a case of sarcoidosis.

Journal: Indian journal of dermatology 20110101

Title: Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma.

Journal: German medical science : GMS e-journal 20110101

Title: Chemical biology of lysine demethylases.

Journal: Current chemical genomics 20110101

Title: Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.

Journal: PloS one 20110101

Title: Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos.

Journal: International journal of nanomedicine 20110101

Title: Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101.

Journal: Journal of oncology 20110101

Title: Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Journal: Molecular neurodegeneration 20110101

Title: Unusual variants of mycosis fungoides.

Journal: Skinmed 20110101

Title: What is the functional role of the thalidomide binding protein cereblon?

Journal: International journal of biochemistry and molecular biology 20110101

Title: Role of factor xa inhibitors in cancer-associated thrombosis: any new data?

Journal: Advances in hematology 20110101

Title: Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.

Journal: International journal of hepatology 20110101

Title: High-density real-time PCR-based in vivo toxicogenomic screen to predict organ-specific toxicity.

Journal: International journal of molecular sciences 20110101

Title: Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.

Journal: In vivo (Athens, Greece) 20110101

Title: Plasma cell myeloma in a renal transplant recipient: A case report and review of literature.

Journal: Indian journal of nephrology 20110101

Title: Human immunodeficiency virus endocrinopathy.

Journal: Indian journal of endocrinology and metabolism 20110101

Title: Systemic vasculitis with prolonged pyrexia, recurrent facial urticaria, skin nodules, pleural effusions and venous thrombosis: an unusual presentation of an uncommon disease.

Journal: German medical science : GMS e-journal 20110101

Title: Aromatic side-chain cluster of biotin binding site of avidin allows circular dichroism spectroscopic investigation of its ligand binding properties.

Journal: Journal of molecular recognition : JMR 20110101

Title: PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.

Journal: Clinical & developmental immunology 20110101

Title: Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.

Journal: Bone marrow research 20110101

Title: Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney).

Journal: Bone marrow research 20110101

Title: Oncolytic virotherapy for multiple myeloma: past, present, and future.

Journal: Bone marrow research 20110101

Title: Antibody-based therapies in multiple myeloma.

Journal: Bone marrow research 20110101

Title: Langerhans cells histiocytosis with vulvar involvement and responding to thalidomide therapy--case report.

Journal: Anais brasileiros de dermatologia 20110101

Title: [Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101

Title: Cardioprotective effects of glycyrrhizic acid against isoproterenol-induced myocardial ischemia in rats.

Journal: International journal of molecular sciences 20110101

Title: Predicting in vivo anti-hepatofibrotic drug efficacy based on in vitro high-content analysis.

Journal: PloS one 20110101

Title: Climate change and environmental impacts on maternal and newborn health with focus on Arctic populations.

Journal: Global health action 20110101

Title: Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.

Journal: Thrombosis 20110101

Title: Interstitial granulomatous dermatitis: another clinical variant.

Journal: Case reports in dermatology 20110101

Title: The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.

Journal: PloS one 20110101

Title: Modulating mesenchymal stromal cell function with cholesterol synthesis inhibitors.

Journal: Current medicinal chemistry 20110101

Title: Light chain (AL) amyloidosis: update on diagnosis and management.

Journal: Journal of hematology & oncology 20110101

Title: What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Journal: Advances in hematology 20110101

Title: Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.

Journal: PloS one 20110101

Title: Therapy-related myeloid malignancies in myeloma.

Journal: Mediterranean journal of hematology and infectious diseases 20110101

Title: Bortezomib-dexamethasone or vincristine-doxorubicin-dexamethasone as induction therapy followed by thalidomide as maintenance therapy in untreated multiple myeloma patients.

Journal: The Journal of international medical research 20110101

Title: Pharmacovigilance: scope for a dermatologist.

Journal: Indian journal of dermatology 20110101

Title: Ulcerative pyoderma gangrenosum in mixed connective tissue disorder: a rare association and role of azathioprine in the management.

Journal: Indian journal of dermatology 20110101

Title: Gorham's disease of femur.

Journal: Indian journal of orthopaedics 20110101

Title: Recurrent aphthous stomatitis.

Journal: Journal of oral and maxillofacial pathology : JOMFP 20110101

Title: Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.

Journal: Acta clinica Belgica 20110101

Title: Molecules, magic and forgetful fruit flies: the supernatural science of medical gas research.

Journal: Medical gas research 20110101

Title: BioCreative III interactive task: an overview.

Journal: BMC bioinformatics 20110101

Title: Stem cell transplantation for multiple myeloma: current and future status.

Journal: Hematology. American Society of Hematology. Education Program 20110101

Title: What is the benefit of maintenance therapy with lenalidomide or bortezomib after autologous stem cell transplantation in multiple myeloma and what is the risk of developing a secondary primary malignancy?

Journal: Hematology. American Society of Hematology. Education Program 20110101

Title: Immunomodulating drugs in myelodysplastic syndromes.

Journal: Hematology. American Society of Hematology. Education Program 20110101

Title: Targeted treatment for chronic lymphocytic leukemia.

Journal: OncoTargets and therapy 20110101

Title: Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals.

Journal: BMC public health 20110101

Title: Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-XL expression.

Journal: Lipids in health and disease 20110101

Title: Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone.

Journal: Radiation oncology (London, England) 20110101

Title: High grade angiosarcoma arising in fibroadenoma.

Journal: Diagnostic pathology 20110101

Title: Radiotherapy and 'new' drugs-new side effects?

Journal: Radiation oncology (London, England) 20110101

Title: Osteoblastic and vascular endothelial niches, their control on normal hematopoietic stem cells, and their consequences on the development of leukemia.

Journal: Stem cells international 20110101

Title: Primary pleural angiosarcoma as a mimicker of mesothelioma: a case report **VS**.

Journal: Diagnostic pathology 20110101

Title: Bullous Variant of Sweet's Syndrome after Herpes Zoster Virus Infection.

Journal: Case reports in dermatology 20110101

Title: Quality of life assessment in multiple myeloma patients undergoing dose-reduced tandem autologous stem cell transplantation.

Journal: Mediterranean journal of hematology and infectious diseases 20110101

Title: Topical ophthalmic cyclosporine in the treatment of toxic epidermal necrolysis.

Journal: Case reports in medicine 20110101

Title: Managing pregnant women with cancer: personal considerations and a review of the literature.

Journal: Ecancermedicalscience 20110101

Title: Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia.

Journal: Journal of blood medicine 20110101

Title: An update on the management of peripheral T-cell lymphoma and emerging treatment options.

Journal: Journal of blood medicine 20110101

Title: Increased in vitro Cell Proliferation by Chitosan/pGM-CSF Complexes.

Journal: Indian journal of pharmaceutical sciences 20110101

Title: Pain in blood cancers.

Journal: Indian journal of palliative care 20110101

Title: A girl with cutaneous lesions, polyarthritis, and antinuclear antibodies positivity.

Journal: ISRN dermatology 20110101

Title: Multiple myeloma and diabetes.

Journal: ISRN endocrinology 20110101

Title: Reversible pulmonary hypertension related to thalidomide treatment for multiple myeloma.

Journal: Case reports in oncology 20110101

Title: [Thromboprophylaxis in patients with multiply myeloma who receives chemotherapy with thalidomide].

Journal: Likars'ka sprava 20110101

Title: Novel treatment paradigm for elderly patients with multiple myeloma.

Journal: American journal of blood research 20110101

Title: Tumor lysis syndrome in patients with light chain multiple myeloma: report of two cases.

Journal: Chang Gung medical journal 20110101

Title: Tuberculous meningitis: diagnosis and treatment overview.

Journal: Tuberculosis research and treatment 20110101

Title: A case report on holt-oram syndrome (heart-hand).

Journal: ARYA atherosclerosis 20110101

Title: A Case of an Unusually Aggressive Cutaneous Anaplastic Large T-Cell Lymphoma in an HIV Patient Treated with CHOP.

Journal: Case reports in oncological medicine 20110101

Title: Pentoxifylline decreases allodynia and hyperalgesia in a rat model of neuropathic pain.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

Title: Cell death signaling and anticancer therapy.

Journal: Frontiers in oncology 20110101

Title: Combined modality approaches in the management of adult glioblastoma.

Journal: Frontiers in oncology 20110101

Title: Investigational approaches for mesothelioma.

Journal: Frontiers in oncology 20110101

Title: Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.

Journal: BMJ case reports 20110101

Title: Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232).

Journal: Blood 20101223

Title: [The 5q- syndrome].

Journal: La Revue du praticien 20101220

Title: A new standard of care in newly diagnosed multiple myeloma.

Journal: Lancet (London, England) 20101218

Title: Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

Journal: Lancet (London, England) 20101218

Title: Redox stimulation of cardiomyogenesis versus inhibition of vasculogenesis upon treatment of mouse embryonic stem cells with thalidomide.

Journal: Antioxidants & redox signaling 20101215

Title: Thalidomide derivatives for the treatment of neuroinflammation.

Journal: ChemMedChem 20101203

Title: Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study.

Journal: Blood 20101202

Title: Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

Journal: Blood 20101202

Title: Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.

Journal: Blood 20101202

Title: The clinical utility of lenalidomide in multiple myeloma and myelodysplastic syndromes.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20101201

Title: Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines.

Journal: Leukemia research 20101201

Title: Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET.

Journal: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20101201

Title: The lower risk MDS patient at risk of rapid progression.

Journal: Leukemia research 20101201

Title: Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results.

Journal: European radiology 20101201

Title: Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101201

Title: Mesenchymal stem cell as salvage treatment for refractory chronic GVHD.

Journal: Bone marrow transplantation 20101201

Title: Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

Title: The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice.

Journal: Clinical and experimental immunology 20101201

Title: The cost-effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective.

Journal: European journal of haematology 20101201

Title: Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.

Journal: Gynecologic oncology 20101201

Title: Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy.

Journal: Melanoma research 20101201

Title: Are anti-angiogenic drugs useful in neurodegenerative disorders?

Journal: CNS & neurological disorders drug targets 20101201

Title: Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

Title: Current treatments for juvenile idiopathic arthritis.

Journal: Joint, bone, spine : revue du rhumatisme 20101201

Title: Thalidomide for treatment of refractory epilepsy.

Journal: Epilepsy research 20101201

Title: Cranial nerve palsy in multiple myeloma and solitary plasmacytoma.

Journal: Asia-Pacific journal of clinical oncology 20101201

Title: Multiple myeloma presenting as eosinophilic pleural effusion.

Journal: Asia-Pacific journal of clinical oncology 20101201

Title: The DAC system and associations with multiple myeloma.

Journal: Investigational new drugs 20101201

Title: [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].

Journal: Annales de dermatologie et de venereologie 20101201

Title: Myeloma: making sense of a complex blood cancer.

Journal: British journal of nursing (Mark Allen Publishing) 20101201

Title: Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5.

Journal: Cancer genetics and cytogenetics 20101201

Title: Ten years of improvement in the management of multiple myeloma: 2000-2010.

Journal: Clinical lymphoma, myeloma & leukemia 20101201

Title: Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.

Journal: Investigational new drugs 20101201

Title: [Therapeutic efficacy of bortezomib-based chemotherapy on 40 patients with multiple myeloma].

Journal: Zhongguo shi yan xue ye xue za zhi 20101201

Title: Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma.

Journal: The Korean journal of internal medicine 20101201

Title: [What's new in dermatological research?].

Journal: Annales de dermatologie et de venereologie 20101201

Title: The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.

Journal: Cancer microenvironment : official journal of the International Cancer Microenvironment Society 20101201

Title: Novel agents for the treatment of chronic lymphocytic leukemia.

Journal: Clinical advances in hematology & oncology : H&O 20101201

Title: Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903.

Journal: Blood 20101125

Title: Dose escalation of lenalidomide in relapsed or refractory acute leukemias.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101120

Title: Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101120

Title: Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials.

Journal: JAMA 20101117

Title: [Dynamic alterations of VEGF and intervention of its expression on effect of hepatocyte malignant transformation].

Journal: Zhonghua yi xue za zhi 20101116

Title: Concise synthesis and antiangiogenic activity of artemisinin-glycolipid hybrids on chorioallantoic membranes.

Journal: Bioorganic & medicinal chemistry letters 20101115

Title: [Carcinoid tumors].

Journal: Orvosi hetilap 20101114

Title: Case 23-2010: Unusual paraprotein effects in MGUS--treat or not?

Journal: The New England journal of medicine 20101104

Title: Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.

Journal: Leukemia research 20101101

Title: Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease.

Journal: The American journal of hospice & palliative care 20101101

Title: A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.

Journal: Journal of neuro-oncology 20101101

Title: Prenatal and perinatal risk factors for autism in China.

Journal: Journal of autism and developmental disorders 20101101

Title: Extramedullary manifestations of multiple myeloma in the thyroid gland and in the lungs: excellent response to therapy.

Journal: Annals of hematology 20101101

Title: Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).

Journal: Experimental neurology 20101101

Title: Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin.

Journal: Annals of hematology 20101101

Title: Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.

Journal: Current molecular pharmacology 20101101

Title: TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury.

Journal: Pain 20101101

Title: Lenalidomide induces remission and mixed quantitative chimerism fluctuations in refractory and relapsed myeloid malignancy with del (5).

Journal: Leukemia research 20101101

Title: Recent advances of IMiDs in cancer therapy.

Journal: Current opinion in oncology 20101101

Title: Mechanisms involved in IL-6-induced muscular mechanical hyperalgesia in mice.

Journal: Pain 20101101

Title: Efficacy of the association of lenalidomide to erythropoiesis-stimulating agents in del (5q) MDS patients refractory to single-agent lenalidomide.

Journal: Leukemia 20101101

Title: A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.

Journal: Neuro-oncology 20101101

Title: Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q).

Journal: Leukemia 20101101

Title: Maintenance and consolidation strategies in non-Hodgkin's lymphoma: A review of the data.

Journal: Current oncology reports 20101101

Title: Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

Journal: Leukemia 20101101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma.

Journal: Leukemia & lymphoma 20101101

Title: Myelodysplastic syndromes--many new drugs, little therapeutic progress.

Journal: Mayo Clinic proceedings 20101101

Title: Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

Journal: The Lancet. Oncology 20101101

Title: Myocarditis during lenalidomide therapy.

Journal: The Annals of pharmacotherapy 20101101

Title: Thalidomide enhances cyclophosphamide and dexamethasone-mediated cytotoxicity towards cultured chronic lymphocytic leukaemia cells.

Journal: Oncology reports 20101101

Title: Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.

Journal: British journal of haematology 20101101

Title: Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.

Journal: Leukemia & lymphoma 20101101

Title: Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues.

Journal: The Lancet. Oncology 20101101

Title: Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20101101

Title: Stroke after treatment with bortezomib and dexamethasone in a Chinese patient with extramedullary relapse of multiple myeloma.

Journal: International journal of clinical pharmacology and therapeutics 20101101

Title: Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials.

Journal: Cancer biology & therapy 20101101

Title: DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?

Journal: Leukemia & lymphoma 20101101

Title: Long-term disease control in multiple myeloma: the impact of the dual mechanism of action of lenalidomide. Introduction and overview.

Journal: Blood reviews 20101101

Title: Lenalidomide mode of action: linking bench and clinical findings.

Journal: Blood reviews 20101101

Title: Lenalidomide: an update on evidence from clinical trials.

Journal: Blood reviews 20101101

Title: Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies.

Journal: Blood reviews 20101101

Title: Liquid-diet with alcohol alters maternal, fetal and placental weights and the expression of molecules involved in integrin signaling in the fetal cerebral cortex.

Journal: International journal of environmental research and public health 20101101

Title: Refractory chronic lymphocytic leukemia--new therapeutic strategies.

Journal: Oncotarget 20101101

Title: Mechanisms of HIV-associated lymphocyte apoptosis: 2010.

Journal: Cell death & disease 20101101

Title: [New treatment strategy for Crow-Fukase (POEMS) syndrome].

Journal: Rinsho shinkeigaku = Clinical neurology 20101101

Title: Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.

Journal: Blood 20101028

Title: γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents.

Journal: The Journal of biological chemistry 20101022

Title: PI3K/Akt signaling pathway is required for neuroprotection of thalidomide on hypoxic-ischemic cortical neurons in vitro.

Journal: Brain research 20101021

Title: B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.

Journal: Nature communications 20101019

Title: [Bortezomib-based regimen for the treatment of 110 multiple myeloma patients].

Journal: Zhonghua yi xue za zhi 20101019

Title: Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia.

Journal: Journal of the neurological sciences 20101015

Title: Actions of thalidomide in producing vascular relaxations.

Journal: European journal of pharmacology 20101010

Title: LPS-induced knee-joint reactive arthritis and spinal cord glial activation were reduced after intrathecal thalidomide injection in rats.

Journal: Life sciences 20101009

Title: Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series.

Journal: Annals of hematology 20101001

Title: A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma.

Journal: Annals of hematology 20101001

Title: Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma.

Journal: Haematologica 20101001

Title: Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents.

Journal: Leukemia research 20101001

Title: First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro.

Journal: European journal of haematology 20101001

Title: Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.

Journal: Cancer 20101001

Title: Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma.

Journal: Cancer 20101001

Title: p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways.

Journal: Cellular signalling 20101001

Title: The protective effect of thalidomide on left ventricular function in a rat model of diabetic cardiomyopathy.

Journal: European journal of heart failure 20101001

Title: Progress in allogeneic transplantation for multiple myeloma.

Journal: European journal of haematology 20101001

Title: Development of target-specific treatments in multiple myeloma.

Journal: British journal of haematology 20101001

Title: The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.

Journal: Leukemia research 20101001

Title: Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.

Journal: European journal of haematology 20101001

Title: Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.

Journal: American journal of hematology 20101001

Title: Bortezomib plus thalidomide for newly diagnosed multiple myeloma in China.

Journal: Anatomical record (Hoboken, N.J. : 2007) 20101001

Title: Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.

Journal: The Lancet. Oncology 20101001

Title: Optimising bortezomib in newly diagnosed multiple myeloma.

Journal: The Lancet. Oncology 20101001

Title: Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.

Journal: Leukemia 20101001

Title: Clarithromycin attenuates autophagy in myeloma cells.

Journal: International journal of oncology 20101001

Title: Reflections on attribution and decisions in pharmacovigilance.

Journal: Drug safety 20101001

Title: Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation.

Journal: Leukemia & lymphoma 20101001

Title: Lenalidomide: a synthetic compound with an evolving role in cancer management.

Journal: Hematology (Amsterdam, Netherlands) 20101001

Title: Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs.

Journal: American journal of hematology 20101001

Title: Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.

Journal: British journal of pharmacology 20101001

Title: [Current treatment strategies for multiple myeloma].

Journal: Therapeutische Umschau. Revue therapeutique 20101001

Title: Sinus bradycardia related to methadone in a patient with myeloma receiving thalidomide therapy.

Journal: Palliative medicine 20101001

Title: An epidemiologist's journey from typhus to thalidomide, and from the Soviet Union to Seveso.

Journal: Journal of the Royal Society of Medicine 20101001

Title: Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes.

Journal: Expert review of anticancer therapy 20101001

Title: Multiple myeloma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20101001

Title: Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trials.

Journal: Clinical lymphoma, myeloma & leukemia 20101001

Title: Plasma cell leukemia: concepts and management.

Journal: Expert review of hematology 20101001

Title: Multiple myeloma in the elderly: when to treat, when to go to transplant.

Journal: Oncology (Williston Park, N.Y.) 20101001

Title: Lenalidomide: myocardial infarction.

Journal: Prescrire international 20101001

Title: Management of central nervous system tuberculosis in children: light and shade.

Journal: European review for medical and pharmacological sciences 20101001

Title: The multi-systemic nature of diabetes mellitus: Genotype or phenotype?

Journal: North American journal of medical sciences 20101001

Title: The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.

Journal: Blood 20100930

Title: Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.

Journal: British journal of cancer 20100928

Title: Efforts toward elucidating Thalidomide's molecular target: an expedient synthesis of the first Thalidomide biotin analogue.

Journal: Organic & biomolecular chemistry 20100921

Title: Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis.

Journal: Blood 20100916

Title: Persistent malignant stem cells in del(5q) myelodysplasia in remission.

Journal: The New England journal of medicine 20100909

Title: Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma.

Journal: Blood 20100902

Title: Multiple myeloma: management of adverse events.

Journal: Medical oncology (Northwood, London, England) 20100901

Title: Numerical scoring for the BILAG-2004 index.

Journal: Rheumatology (Oxford, England) 20100901

Title: Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety.

Journal: Annals of hematology 20100901

Title: Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma.

Journal: Haematologica 20100901

Title: Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma.

Journal: Leukemia research 20100901

Title: Improved survival of multiple myeloma patients with late relapse after high-dose treatment and stem cell support, a population-based study of 348 patients in Denmark in 1994-2004.

Journal: European journal of haematology 20100901

Title: Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.

Journal: European journal of haematology 20100901

Title: Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion.

Journal: European journal of haematology 20100901

Title: Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs.

Journal: European journal of haematology 20100901

Title: Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii.

Journal: Clinical rheumatology 20100901

Title: Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society 20100901

Title: The Thalidomide renaissance.

Journal: Gastroenterologie clinique et biologique 20100901

Title: Rituximab-lenalidomide-dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma.

Journal: Leukemia & lymphoma 20100901

Title: Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.

Journal: American journal of hematology 20100901

Title: Necrosis following skull base irradiation and stem cell transplant for multiple myeloma.

Journal: American journal of hematology 20100901

Title: Signaling by members of the TGF-beta family in vascular morphogenesis and disease.

Journal: Trends in cell biology 20100901

Title: An unusual case of IgE-multiple myeloma presenting with systemic amyloidosis 2 years after cervical plasmacytoma resection.

Journal: International journal of hematology 20100901

Title: Lenalidomide-induced acute interstitial nephritis.

Journal: The oncologist 20100901

Title: Rapamycin and thalidomide treatment of a patient with refractory metastatic gastroesophageal adenocarcinoma: a case report.

Journal: The oncologist 20100901

Title: A case of multicentric Castleman's disease having lung lesion successfully treated with humanized anti-interleukin-6 receptor antibody, tocilizumab.

Journal: Journal of Korean medical science 20100901

Title: Lenalidomide for bortezomib-resistant multiple myeloma.

Journal: Nature reviews. Clinical oncology 20100901

Title: Lenalidomide efficacy in bortezomib-resistant myeloma.

Journal: Nature reviews. Clinical oncology 20100901

Title: Antiallodynic Effect of Thalidomide and Morphine on Rat Spinal Nerve Ligation-induced Neuropathic Pain.

Journal: The Korean journal of pain 20100901

Title: [Current treatment options for myelodysplastic syndromes].

Journal: Deutsche medizinische Wochenschrift (1946) 20100901

Title: [Thalidomide--coverage by health insurance when used for treatment of ENL].

Journal: Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20100901

Title: Reassessing the standard of care in indolent lymphoma: a clinical update to improve clinical practice.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20100901

Title: The potential of immunomodulatory drugs in the treatment of solid tumors.

Journal: Future oncology (London, England) 20100901

Title: Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma?

Journal: The Korean journal of hematology 20100901

Title: The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma.

Journal: The Korean journal of hematology 20100901

Title: Recurrent multiple myeloma presenting as a breast plasmacytoma.

Journal: The Medical journal of Malaysia 20100901

Title: Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy.

Journal: Blood 20100826

Title: The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function.

Journal: Cancer 20100815

Title: Osseous metaplasia late in the course of nephrogenic systemic fibrosis.

Journal: Dermatology online journal 20100815

Title: Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.

Journal: Dermatology online journal 20100815

Title: Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.

Journal: British journal of cancer 20100810

Title: Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Journal: Blood 20100805

Title: Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100801

Title: Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma.

Journal: Annals of hematology 20100801

Title: Epidermal growth factor receptor mutation and diverse tumors: case report and concise literature review.

Journal: Molecular oncology 20100801

Title: Pharmacotherapy of myelodysplastic syndromes.

Journal: Expert opinion on pharmacotherapy 20100801

Title: Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.

Journal: Leukemia & lymphoma 20100801

Title: Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.

Journal: Leukemia & lymphoma 20100801

Title: The temporal dynamics of vertebrate limb development, teratogenesis and evolution.

Journal: Current opinion in genetics & development 20100801

Title: The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study.

Journal: British journal of haematology 20100801

Title: Post-transplant lymphoproliferative disorder presenting as multiple myeloma.

Journal: American journal of hematology 20100801

Title: Immunomodulators in chronic lymphocytic leukemia: where does lenalidomide belong?

Journal: Leukemia & lymphoma 20100801

Title: Urban legends of chemistry.

Journal: Nature chemistry 20100801

Title: A randomized double-blind, positive-control trial of topical thalidomide in erosive oral lichen planus.

Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100801

Title: Hematology: Is thalidomide combination a new option for myeloma?

Journal: Nature reviews. Clinical oncology 20100801

Title: Management of patients with chronic lymphocytic leukemia treated with lenalidomide.

Journal: Clinical journal of oncology nursing 20100801

Title: Treatment of cutaneous lupus erythematosus.

Journal: Lupus 20100801

Title: Access to thalidomide for the treatment of multiple myeloma in Canada: physician behaviours and ethical implications.

Journal: Current oncology (Toronto, Ont.) 20100801

Title: Plasma cell leukaemia and other aggressive plasma cell malignancies.

Journal: British journal of haematology 20100801

Title: The effect of bevacizumab on corneal neovascularization in rabbits.

Journal: Korean journal of ophthalmology : KJO 20100801

Title: Treatment considerations for primary myelofibrosis.

Journal: The Netherlands journal of medicine 20100801

Title: Thalidomide and lenalidomide in primary myelofibrosis.

Journal: The Netherlands journal of medicine 20100801

Title: [Prediction of treatment efficacy by the M-protein reduction rate after the first cycle of VAD therapy for multiple myeloma].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100801

Title: [Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100801

Title: [Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].

Journal: Vnitrni lekarstvi 20100801

Title: Solitary extramedullary plasmacytoma of the bladder: a case report and literature.

Journal: Oncology (Williston Park, N.Y.) 20100801

Title: Rare bladder tumors: caveat emptor.

Journal: Oncology (Williston Park, N.Y.) 20100801

Title: First-line treatment of elderly multiple myeloma patients.

Journal: Clinical advances in hematology & oncology : H&O 20100801

Title: [The efficacy and safety of long-term thalidomide in the treatment of ankylosing spondylitis].

Journal: Zhonghua nei ke za zhi 20100801

Title: Therapeutics Based on microRNA: A New Approach for Liver Cancer.

Journal: Current genomics 20100801

Title: Current and future management options for myelodysplastic syndromes.

Journal: Drugs 20100730

Title: Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells.

Journal: International journal of cancer 20100715

Title: Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.

Journal: Blood 20100715

Title: XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments.

Journal: Blood 20100715

Title: Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide.

Journal: Bioorganic & medicinal chemistry 20100715

Title: Development of tryptase inhibitors derived from thalidomide.

Journal: Bioorganic & medicinal chemistry 20100715

Title: High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study.

Journal: Blood 20100708

Title: Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial.

Journal: Haematologica 20100701

Title: Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.

Journal: Leukemia research 20100701

Title: Efficacy of lenalidomide treatment and complete cytogenetic remission in a case of myelodysplastic syndrome with del(5q) and del(9q).

Journal: Leukemia research 20100701

Title: In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study.

Journal: Inflammatory bowel diseases 20100701

Title: Near-tetraploidy clone can evolve from a hyperdiploidy clone and cause resistance to lenalidomide and bortezomib in a multiple myeloma patient.

Journal: Leukemia research 20100701

Title: Potential teratogenic effects of ultrasound on corticogenesis: implications for autism.

Journal: Medical hypotheses 20100701

Title: Distribution of lenalidomide into semen of healthy men after multiple oral doses.

Journal: Journal of clinical pharmacology 20100701

Title: Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.

Journal: European journal of haematology 20100701

Title: Ultra low dose thalidomide in myeloma revisited.

Journal: British journal of haematology 20100701

Title: Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.

Journal: European journal of cancer (Oxford, England : 1990) 20100701

Title: Thalidomide treatment modulates macrophage pro-inflammatory function and cytokine levels in Klebsiella pneumoniae B5055 induced pneumonia in BALB/c mice.

Journal: International immunopharmacology 20100701

Title: Inflammasome and IL-1beta-mediated disorders.

Journal: Current allergy and asthma reports 20100701

Title: Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?

Journal: Current hematologic malignancy reports 20100701

Title: Effect of thalidomide dithiocarbamate analogs on the intercellular adhesion molecule-1 expression.

Journal: International immunopharmacology 20100701

Title: WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations.

Journal: Leukemia 20100701

Title: Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study.

Journal: Leukemia 20100701

Title: Innovative uses of thalidomide.

Journal: Dermatologic clinics 20100701

Title: Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100701

Title: Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases.

Journal: Journal of child neurology 20100701

Title: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma.

Journal: International journal of hematology 20100701

Title: Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective study.

Journal: Cancer 20100701

Title: Bortezomib plus intermediate-dose dexamethasone and thalidomide in elderly untreated patients with multiple myeloma: a Chinese experience.

Journal: American journal of hematology 20100701

Title: [Oral molecular targeting agents in hematological malignancy].

Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100701

Title: Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders.

Journal: Journal of drugs in dermatology : JDD 20100701

Title: Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

Journal: British journal of cancer 20100629

Title: Human liver microsomal cytochrome P450 3A enzymes involved in thalidomide 5-hydroxylation and formation of a glutathione conjugate.

Journal: Chemical research in toxicology 20100621

Title: Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment arms.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100620

Title: TNF-alpha and its inhibitors in cancer.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: Gemcitabine and lenalidomide combination in a patient with metastatic pancreatic cancer: a case study.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: The combined administration of partially HLA-matched irradiated allogeneic lymphocytes and thalidomide in advanced renal-cell carcinoma: a case report.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: Future directions in immunomodulatory therapy.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.

Journal: The pharmacogenomics journal 20100601

Title: The evolution and impact of therapy in multiple myeloma.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin.

Journal: European journal of haematology 20100601

Title: An appreciation of Diether Neubert and Hans-Joachim Merker's contributions to Reproductive and Developmental Toxicology on their 80th birthday.

Journal: Reproductive toxicology (Elmsford, N.Y.) 20100601

Title: Advances in treatment for relapses and refractory multiple myeloma.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.

Journal: Cancer 20100601

Title: Pharmacological properties of thalidomide and its analogues.

Journal: Recent patents on inflammation & allergy drug discovery 20100601

Title: Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20100601

Title: ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.

Journal: European journal of haematology 20100601

Title: Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis.

Journal: Leukemia & lymphoma 20100601

Title: Regulatory T cell as a target for cancer therapy.

Journal: Archivum immunologiae et therapiae experimentalis 20100601

Title: Enatiomerically pure hydroxycarboxylic acids: current approaches and future perspectives.

Journal: Applied microbiology and biotechnology 20100601

Title: Mechanism of action of immunomodulatory agents in multiple myeloma.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: Why not treat human cancer with interleukin-1 blockade?

Journal: Cancer metastasis reviews 20100601

Title: [Recurrent aphthosis: safety of low dose thalidomide].

Journal: La Revue de medecine interne 20100601

Title: Management of disease- and treatment-related complications in patients with multiple myeloma.

Journal: Medical oncology (Northwood, London, England) 20100601

Title: Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.

Journal: Clinical lymphoma, myeloma & leukemia 20100601

Title: New uses for older drugs: the tales of aspirin, thalidomide, and gabapentin.

Journal: Mayo Clinic proceedings 20100601

Title: Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie.

Journal: Mayo Clinic proceedings 20100601

Title: Tautomerism in large databases.

Journal: Journal of computer-aided molecular design 20100601

Title: Safe and effective use of plerixafor plus G-CSF in dialysis-dependent renal failure.

Journal: American journal of hematology 20100601

Title: Patient perceptions associated with chemotherapy-induced peripheral neuropathy.

Journal: Clinical journal of oncology nursing 20100601

Title: In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines.

Journal: Birth defects research. Part C, Embryo today : reviews 20100601

Title: Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits.

Journal: Birth defects research. Part C, Embryo today : reviews 20100601

Title: Cost-effectiveness of lenalidomide in multiple myeloma.

Journal: Expert review of pharmacoeconomics & outcomes research 20100601

Title: Useless perinatal therapies.

Journal: Neonatology 20100601

Title: [Pathogenesis and management of hemorrhage and thrombosis in plasma cell dyscrasias].

Journal: Zhongguo shi yan xue ye xue za zhi 20100601

Title: Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.

Journal: British journal of clinical pharmacology 20100601

Title: Correlation of seizures and biochemical parameters of oxidative stress in experimentally induced inflammatory rat models.

Journal: Fundamental & clinical pharmacology 20100601

Title: Unsuccessful treatment of recalcitrant cutaneous discoid lupus erythematosus with photodynamic therapy.

Journal: Photodermatology, photoimmunology & photomedicine 20100601

Title: Regression of major recurrent aphthous ulcerations using a combination of intralesional corticosteroids and levamisole: a case report.

Journal: Clinics (Sao Paulo, Brazil) 20100601

Title: Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated.

Journal: PLoS neglected tropical diseases 20100601

Title: Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/reperfusion.

Journal: Transplantation proceedings 20100601

Title: Lenalidomide: Stevens-Johnson syndrome.

Journal: Prescrire international 20100601

Title: [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100601

Title: Clinical features of multiple myeloma invasion of the central nervous system in Chinese patients.

Journal: Chinese medical journal 20100601

Title: Winning a won game: caffeine panacea for obesity syndemic.

Journal: Current neuropharmacology 20100601

Title: Multiple myeloma with huge extramedullary plasmacytomas.

Journal: The Korean journal of hematology 20100601

Title: Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study.

Journal: The Korean journal of hematology 20100601

Title: Neurobehavioral manifestations of developmental impairment of the brain.

Journal: Interdisciplinary toxicology 20100601

Title: Advances in haematological pharmacotherapy in 21st century.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 20100601

Title: Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance.

Journal: Blood 20100527

Title: Importance of achieving a complete response in multiple myeloma, and the impact of novel agents.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100520

Title: Supramolecular dynamics of thalidomide and its derivatives in water-sediment system.

Journal: Chirality 20100505

Title: Palliative oncology: thalidomide.

Journal: The American journal of hospice & palliative care 20100501

Title: Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.

Journal: Inflammatory bowel diseases 20100501

Title: Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study.

Journal: Annals of hematology 20100501

Title: Salvage treatment with upfront melphalan 100 mg/m(2) and consolidation with novel drugs for fulminant progression of multiple myeloma.

Journal: Annals of hematology 20100501

Title: Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue.

Journal: Journal of neuro-oncology 20100501

Title: In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.

Journal: Haematologica 20100501

Title: Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP).

Journal: Annals of hematology 20100501

Title: Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.

Journal: Haematologica 20100501

Title: Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis.

Journal: European journal of haematology 20100501

Title: Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100501

Title: Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer.

Journal: Cancer investigation 20100501

Title: A prospective double-blind, placebo-controlled study of thalidomide sensory symptoms in an elderly population with age-related macular degeneration.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100501

Title: Antiangiogenic tumor treatment: noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound.

Journal: Academic radiology 20100501

Title: Multiple myeloma: chemotherapy or transplantation in the era of new drugs.

Journal: European journal of haematology 20100501

Title: Renal recovery with lenalidomide in a patient with bortezomib-resistant multiple myeloma.

Journal: Nature reviews. Clinical oncology 20100501

Title: Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501

Title: Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501

Title: Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma.

Journal: Leukemia 20100501

Title: Nonspecific interstitial pneumonitis after bortezomib and thalidomide treatment in a multiple myeloma patient.

Journal: Yonsei medical journal 20100501

Title: Thalidomide is a highly effective treatment of MDS: a single-hospital experience in Japan.

Journal: International journal of hematology 20100501

Title: Target identification: unravelling thalidomide teratogenicity.

Journal: Nature reviews. Drug discovery 20100501

Title: Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis.

Journal: Medicine 20100501

Title: Clinical management of myeloma--state of the art.

Journal: Cancer treatment reviews 20100501

Title: Presentation and risk stratification--improving prognosis for patients with multiple myeloma.

Journal: Cancer treatment reviews 20100501

Title: Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.

Journal: Cancer treatment reviews 20100501

Title: Management of treatment-related adverse events in patients with multiple myeloma.

Journal: Cancer treatment reviews 20100501

Title: Multiple myeloma - current issues and controversies.

Journal: Cancer treatment reviews 20100501

Title: Optimising patient outcomes in myeloma.

Journal: Cancer treatment reviews 20100501

Title: Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Journal: Acta histochemica et cytochemica 20100501

Title: Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.

Journal: Klinische Padiatrie 20100501

Title: Antiangiogenic therapy combined with TACE - more beneficial therapeutic effect in HCC.

Journal: Alimentary pharmacology & therapeutics 20100501

Title: Frontline regimens for multiple myeloma patients.

Journal: Clinical advances in hematology & oncology : H&O 20100501

Title: [Reinventing thalidomide under high supervision].

Journal: Annales pharmaceutiques francaises 20100501

Title: Autism from a biometric perspective.

Journal: International journal of environmental research and public health 20100501

Title: Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy.

Journal: Clinical advances in hematology & oncology : H&O 20100501

Title: Toxic epidermal necrolysis from a cigarette burn.

Journal: The western journal of emergency medicine 20100501

Title: A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

Journal: British journal of cancer 20100427

Title: [Thalidomide: new therapeutic indications?].

Journal: Revue medicale suisse 20100421

Title: Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

Title: Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100420

Title: Three cases of bortezomib-resistant multiple myeloma with extramedullary masses.

Journal: The Tokai journal of experimental and clinical medicine 20100420

Title: Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care.

Journal: British journal of cancer 20100413

Title: Primary prevention of venous thromboembolism in medical and surgical oncology patients.

Journal: British journal of cancer 20100413

Title: Epidemiology and pathophysiology of cancer-associated thrombosis.

Journal: British journal of cancer 20100413

Title: [Clinical study of multiple myeloma: a report of 182 cases].

Journal: Zhonghua yi xue za zhi 20100413

Title: A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro.

Journal: Molecular biology reports 20100401

Title: Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.

Journal: Leukemia research 20100401

Title: Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.

Journal: Annals of hematology 20100401

Title: Treatment of 5q-syndrome with lenalidomide in an HIV-positive patient under cART.

Journal: Annals of hematology 20100401

Title: Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity.

Journal: The British journal of ophthalmology 20100401

Title: A pilot study on changes of macrophage colony stimulating factor and transforming growth factor beta1 in male patients with ankylosing spondylitis taking thalidomide.

Journal: Annals of the rheumatic diseases 20100401

Title: Efficacy of lenalidomide in an sAML patient with del 5q relapsing after reduced-intensity allogeneic stem cell transplantation performed in complete remission.

Journal: Bone marrow transplantation 20100401

Title: Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.

Journal: Annals of hematology 20100401

Title: Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease.

Journal: Journal of neuro-oncology 20100401

Title: Thalidomide-related vessel thrombosis in microsurgical free tissue transfer.

Journal: Journal of reconstructive microsurgery 20100401

Title: Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.

Journal: Blood 20100401

Title: Treatment response to bortezomib in multiple myeloma correlates with plasma hepatocyte growth factor concentration and bone marrow thrombospondin concentration.

Journal: European journal of haematology 20100401

Title: alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy.

Journal: Journal of medical microbiology 20100401

Title: What causes autism? Exploring the environmental contribution.

Journal: Current opinion in pediatrics 20100401

Title: The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.

Journal: Liver international : official journal of the International Association for the Study of the Liver 20100401

Title: In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine.

Journal: Cancer chemotherapy and pharmacology 20100401

Title: Thalidomide inhibited the synthesis of IgM and IgG whereas Thalidomide+Dexamethasone and Dexamethasone alone acted as co-stimulants with pokeweed and enhanced their synthesis.

Journal: International immunopharmacology 20100401

Title: Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis.

Journal: Leukemia 20100401

Title: Lenalidomide in multiple myeloma: current role and future directions.

Journal: Expert opinion on pharmacotherapy 20100401

Title: Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100401

Title: Update on the management of antibiotic allergy.

Journal: Allergy, asthma & immunology research 20100401

Title: Novel agents in development for peripheral T-cell lymphoma.

Journal: Seminars in hematology 20100401

Title: Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.

Journal: Seminars in hematology 20100401

Title: Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

Journal: Hematology/oncology clinics of North America 20100401

Title: Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.

Journal: Nature medicine 20100401

Title: Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program.

Journal: Clinical lymphoma, myeloma & leukemia 20100401

Title: Taking thalidomide out of rehab.

Journal: Nature medicine 20100401

Title: Thalidomide's early effects.

Journal: Nature medicine 20100401

Title: Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in rats.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT 20100401

Title: [Advances and perspectives in treatment for refractory neuropathies with special reference to immune-mediated neuropathies and Crow-Fukase syndrome].

Journal: Rinsho shinkeigaku = Clinical neurology 20100401

Title: [Changes of gene expression profile in human myeloma cell line induced by thalidomide].

Journal: Zhongguo shi yan xue ye xue za zhi 20100401

Title: [Crow-Fukase (POEMS) syndrome].

Journal: Brain and nerve = Shinkei kenkyu no shinpo 20100401

Title: Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD).

Journal: Hematology (Amsterdam, Netherlands) 20100401

Title: Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact.

Journal: Thrombosis research 20100401

Title: Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.

Journal: European review for medical and pharmacological sciences 20100401

Title: Effect of thalidomide on nitric oxide production in lipopolysaccharide-activated RAW 264.7 cells.

Journal: Journal of drugs in dermatology : JDD 20100401

Title: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.

Journal: Clinical advances in hematology & oncology : H&O 20100401

Title: Pharmacovigilance in vaccines.

Journal: Indian journal of pharmacology 20100401

Title: Phytochemicals in cancer prevention and therapy: truth or dare?

Journal: Toxins 20100401

Title: Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.

Journal: British journal of cancer 20100330

Title: Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction.

Journal: Blood 20100325

Title: Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.

Journal: British journal of cancer 20100316

Title: Identification of a primary target of thalidomide teratogenicity.

Journal: Science (New York, N.Y.) 20100312

Title: [Paraproteinemia and renal diseases].

Journal: Revue medicale suisse 20100303

Title: Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100301

Title: Differential activities of thalidomide and isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells.

Journal: Leukemia research 20100301

Title: Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis.

Journal: Annals of hematology 20100301

Title: Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years.

Journal: Annals of hematology 20100301

Title: Anti-fibrotic effect of thalidomide through inhibiting TGF-beta-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20100301

Title: Toxic epidermal necrolysis (Lyell's disease).

Journal: Burns : journal of the International Society for Burn Injuries 20100301

Title: Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion.

Journal: Haematologica 20100301

Title: Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways.

Journal: Haematologica 20100301

Title: Comparative effects of drugs on P-glycoprotein expression and activity using rat and human trophoblast models.

Journal: Toxicology in vitro : an international journal published in association with BIBRA 20100301

Title: DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.

Journal: European journal of haematology 20100301

Title: The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.

Journal: European journal of haematology 20100301

Title: Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.

Journal: European journal of haematology 20100301

Title: Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells.

Journal: British journal of haematology 20100301

Title: High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma.

Journal: Leukemia & lymphoma 20100301

Title: A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy.

Journal: Cancer chemotherapy and pharmacology 20100301

Title: Antiangiogenesis agents in the treatment of soft tissue sarcomas.

Journal: Cancer 20100301

Title: Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone.

Journal: Leukemia 20100301

Title: Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients.

Journal: Leukemia 20100301

Title: Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301

Title: Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function.

Journal: Current cancer drug targets 20100301

Title: Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.

Journal: Veterinary pathology 20100301

Title: Effects of T-type calcium channel blockers and thalidomide on contractions of rat vas deferens.

Journal: British journal of pharmacology 20100301

Title: Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100301

Title: Chest nodule in a patient with multiple myeloma.

Journal: International journal of hematology 20100301

Title: Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.

Journal: Neuro-oncology 20100301

Title: Novel approaches for myelodysplastic syndromes: beyond hypomethylating agents.

Journal: Current opinion in hematology 20100301

Title: Lenalidomide-induced interstitial lung disease.

Journal: Pharmacotherapy 20100301

Title: Targeted therapies: Thalidomide in lung cancer therapy-what have we learned?

Journal: Nature reviews. Clinical oncology 20100301

Title: Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion.

Journal: Haematologica 20100301

Title: The evolution of antiepileptic drug development and regulation.

Journal: Epileptic disorders : international epilepsy journal with videotape 20100301

Title: Generalized necrobiotic xanthogranuloma successfully treated with lenalidomide.

Journal: Journal of drugs in dermatology : JDD 20100301

Title: Effectiveness of thalidomide and tamoxifen in preventing neointimal hyperplasia in experimental vascular injury in rats.

Journal: Transplantation proceedings 20100301

Title: [Picture in clinical hematology no.42].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100301

Title: [Analysis of high-risk multiple myeloma patients treated with high-dose chemotherapy].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100301

Title: [Factors affecting the response of thalidomide therapy for patients with multiple myeloma].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100301

Title: [Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis].

Journal: Vnitrni lekarstvi 20100301

Title: Update on HHV-8-Associated Malignancies.

Journal: Current infectious disease reports 20100301

Title: Best practices in the management of newly diagnosed multiple myeloma patients who will not undergo transplant.

Journal: Oncology (Williston Park, N.Y.) 20100301

Title: Tailoring treatment for multiple myeloma patients with relapsed and refractory disease.

Journal: Oncology (Williston Park, N.Y.) 20100301

Title: Drug-mediated and cellular immunotherapy in multiple myeloma.

Journal: Immunotherapy 20100301

Title: Al-Awadi/Raas-Rothschild syndrome in a newborn with additional anomalies.

Journal: Journal of clinical research in pediatric endocrinology 20100301

Title: Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients.

Journal: Blood 20100218

Title: Treatment options for small cell lung cancer - do we have more choice?

Journal: British journal of cancer 20100216

Title: Integrated pathways for neutrophil recruitment and inflammation in leprosy.

Journal: The Journal of infectious diseases 20100215

Title: A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.

Journal: Blood 20100211

Title: A TAD better for myeloma therapy?

Journal: Blood 20100211

Title: Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210

Title: [Lenalidomide in the treatment of transfusion dependent myelodysplastic syndromes].

Journal: Ugeskrift for laeger 20100208

Title: Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.

Journal: Archives of gynecology and obstetrics 20100201

Title: Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

Journal: Bone marrow transplantation 20100201

Title: CR with lenalidomide in del(5)(q13q33) AML relapsing after allogeneic hematopoietic SCT.

Journal: Bone marrow transplantation 20100201

Title: Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.

Journal: Journal of neuro-oncology 20100201

Title: Constitutive down-regulation of Osterix in osteoblasts from myeloma patients: in vitro effect of Bortezomib and Lenalidomide.

Journal: Leukemia research 20100201

Title: Extended-schedule dose-dense temozolomide in refractory gliomas.

Journal: Journal of neuro-oncology 20100201

Title: Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide.

Journal: Annals of hematology 20100201

Title: Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100201

Title: Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient.

Journal: Sexually transmitted diseases 20100201

Title: Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma.

Journal: British journal of haematology 20100201

Title: Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion.

Journal: British journal of haematology 20100201

Title: Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.

Journal: British journal of haematology 20100201

Title: Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC).

Journal: American journal of physiology. Gastrointestinal and liver physiology 20100201

Title: Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria.

Journal: Pharmacoepidemiology and drug safety 20100201

Title: Thalidomide-induced phrenic nerve paralysis.

Journal: Leukemia & lymphoma 20100201

Title: Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.

Journal: Leukemia & lymphoma 20100201

Title: Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

Journal: British journal of pharmacology 20100201

Title: Phase1/-2 study of Pomalidomide in myelofibrosis.

Journal: American journal of hematology 20100201

Title: Pomalidomide: a new IMiD with remarkable activity in both multiple myeloma and myelofibrosis.

Journal: American journal of hematology 20100201

Title: A case of histiocytic sarcoma presenting with primary bone marrow involvement.

Journal: Journal of Korean medical science 20100201

Title: Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.

Journal: Haematologica 20100201

Title: Complications of multiple myeloma therapy, part 2: risk reduction and management of venous thromboembolism, osteonecrosis of the jaw, renal complications, and anemia.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20100201

Title: The role of maintenance therapy in the treatment of multiple myeloma.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20100201

Title: In the age of novel therapies, what defines high-risk multiple myeloma?

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20100201

Title: Complications of multiple myeloma therapy, part 1: risk reduction and management of peripheral neuropathy and asthenia.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20100201

Title: Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.

Journal: The oncologist 20100201

Title: Primary epithelioid angiosarcoma of the breast masquerading as carcinoma.

Journal: Current oncology (Toronto, Ont.) 20100201

Title: The current status and future of multiple myeloma in the clinic.

Journal: Clinical lymphoma, myeloma & leukemia 20100201

Title: Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II study.

Journal: Clinical lymphoma, myeloma & leukemia 20100201

Title: Pruritus: control of itch in patients undergoing dialysis.

Journal: Skin therapy letter 20100201

Title: [Retrospective analysis of thalidomide therapy in patients with relapsed/refractory multiple myeloma].

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100201

Title: Angiogenesis: Future of pharmacological modulation.

Journal: Indian journal of pharmacology 20100201

Title: Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma.

Journal: Blood 20100128

Title: The biology of myelodysplastic syndromes: unity despite heterogeneity.

Journal: Hematology reports 20100126

Title: Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia.

Journal: Blood 20100121

Title: PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer.

Journal: British journal of cancer 20100119

Title: Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508.

Journal: Cancer 20100115

Title: New thalidomide analogues derived through Sonogashira or Suzuki reactions and their TNF expression inhibition profiles.

Journal: Bioorganic & medicinal chemistry 20100115

Title: [Molecular-targeted therapy of multiple myeloma].

Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20100110

Title: Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

Journal: Journal of the National Cancer Institute 20100106

Title: [Two faces of Janus. Coexistence of systemic lupus erythematosus and psoriasis in the same patient].

Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20100101

Title: Total therapy-based treatment for multiple myeloma--a single center experience.

Journal: Annals of hematology 20100101

Title: Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?

Journal: Annals of hematology 20100101

Title: Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma.

Journal: European journal of nuclear medicine and molecular imaging 20100101

Title: Cancer cachexia: medical management.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100101

Title: Fetal malformations and early embryonic gene expression response in cynomolgus monkeys maternally exposed to thalidomide.

Journal: Reproductive toxicology (Elmsford, N.Y.) 20100101

Title: Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat.

Journal: Neuroscience research 20100101

Title: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors.

Journal: Journal of cancer research and clinical oncology 20100101

Title: Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment.

Journal: Human genetics 20100101

Title: Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide.

Journal: The Journal of infection 20100101

Title: Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.

Journal: The Lancet. Oncology 20100101

Title: Towards a new standard of care for patients with myeloma?

Journal: The Lancet. Oncology 20100101

Title: Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma.

Journal: Cancer 20100101

Title: Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma.

Journal: Neoplasma 20100101

Title: Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100101

Title: Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents.

Journal: Dermatology (Basel, Switzerland) 20100101

Title: Activity of thalidomide and lenalidomide in mantle cell lymphoma.

Journal: Acta haematologica 20100101

Title: Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.

Journal: Leukemia 20100101

Title: The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.

Journal: Journal of neuro-oncology 20100101

Title: The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.

Journal: Journal of neuro-oncology 20100101

Title: Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.

Journal: Rheumatology (Oxford, England) 20100101

Title: Resolving a double standard for risk management of thalidomide: an evaluation of two different risk management programmes in Japan.

Journal: Drug safety 20100101

Title: Targeting the TNF-alpha pathway in sarcoidosis.

Journal: Expert opinion on therapeutic targets 20100101

Title: New agents for the treatment of genetically high-risk chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma 20100101

Title: New insights in synovial angiogenesis.

Journal: Joint, bone, spine : revue du rhumatisme 20100101

Title: [New drugs in metastatic castration-resistant prostate cancer].

Journal: Bulletin du cancer 20100101

Title: Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination.

Journal: Dermatology (Basel, Switzerland) 20100101

Title: Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.

Journal: American journal of hematology 20100101

Title: New treatments for myeloma.

Journal: Joint, bone, spine : revue du rhumatisme 20100101

Title: Compounds in clinical Phase III and beyond.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20100101

Title: Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism.

Journal: Arthritis and rheumatism 20100101

Title: Synthesis and configurational stability of (S)- and (R)-deuteriothalidomides.

Journal: Chemical & pharmaceutical bulletin 20100101

Title: Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand.

Journal: Journal of hematology & oncology 20100101

Title: Non- medical prescribing in Australasia and the UK: the case of podiatry.

Journal: Journal of foot and ankle research 20100101

Title: Thalidomide and lenalidomide as new therapeutics for the treatment of chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma 20100101

Title: Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics.

Journal: Leukemia & lymphoma 20100101

Title: 5-hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization.

Journal: Molecular cancer research : MCR 20100101

Title: Antivascular therapy for epithelial ovarian cancer.

Journal: Journal of oncology 20100101

Title: The potential benefits of low-molecular-weight heparins in cancer patients.

Journal: Journal of hematology & oncology 20100101

Title: Lenalidomide (Revlimid) combined with continuous oral cyclophosphamide (endoxan) and prednisone (REP) is effective in lenalidomide/dexamethasone-refractory myeloma.

Journal: British journal of haematology 20100101

Title: Current multiple myeloma treatment strategies with novel agents: a European perspective.

Journal: The oncologist 20100101

Title: New developments in the treatment of patients with multiple myeloma.

Journal: The Netherlands journal of medicine 20100101

Title: Foetal haemoglobin inducers and thalassaemia: novel achievements.

Journal: Blood transfusion = Trasfusione del sangue 20100101

Title: Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy.

Journal: Blood transfusion = Trasfusione del sangue 20100101

Title: Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients.

Journal: BMC cancer 20100101

Title: Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis.

Journal: Journal of neuroinflammation 20100101

Title: [Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].

Journal: Annales de dermatologie et de venereologie 20100101

Title: Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.

Journal: Orphanet journal of rare diseases 20100101

Title: Successful thalidomide treatment of adult solitary perianal Langerhans cell histiocytosis.

Journal: European journal of dermatology : EJD 20100101

Title: Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?

Journal: Obstetrics and gynecology international 20100101

Title: Bendamustine in patients with relapsed or refractory multiple myeloma.

Journal: European journal of medical research 20100101

Title: Angiogenesis inhibition in prostate cancer: current uses and future promises.

Journal: Journal of oncology 20100101

Title: Recurrent hemorrhagic pericardial effusion in a child due to diffuse lymphangiohemangiomatosis: a case report.

Journal: Journal of medical case reports 20100101

Title: Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis.

Journal: Pediatric rheumatology online journal 20100101

Title: Successful treatment of POEMS syndrome complicated by severe congestive heart failure with thalidomide.

Journal: Internal medicine (Tokyo, Japan) 20100101

Title: Trends in the incidence and survival of multiple myeloma in South East England 1985-2004.

Journal: BMC cancer 20100101

Title: Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.

Journal: PloS one 20100101

Title: Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Journal: PPAR research 20100101

Title: Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature.

Journal: Diagnostic pathology 20100101

Title: Idiopathic sclerosing mesenteritis in paediatrics: Report of a successfully treated case and a review of literature.

Journal: Pediatric rheumatology online journal 20100101

Title: Metastatic breast cancer or multiple myeloma? Camouflage by lytic lesions.

Journal: Journal of oncology 20100101

Title: Temozolomide-induced myelodysplasia.

Journal: Advances in hematology 20100101

Title: EVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantage.

Journal: BMC clinical pharmacology 20100101

Title: Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.

Journal: Journal of cutaneous medicine and surgery 20100101

Title: Response to hydralazine-valproate in a patient with mycosis fungoides.

Journal: Case reports in medicine 20100101

Title: [Elderly patients with myelodysplastic syndrome with del 5q receiving lenalidomide: two case reports with poor prognosis].

Journal: Annales de biologie clinique 20100101

Title: Contraception for adolescents with lupus.

Journal: Pediatric rheumatology online journal 20100101

Title: Cancer-associated thrombosis.

Journal: The open cardiovascular medicine journal 20100101